AFLAC INC - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&A) - Insurance News | InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Newswires
Topics
    • Advisor News
    • Annuity Index
    • Annuity News
    • Companies
    • Earnings
    • Fiduciary
    • From the Field: Expert Insights
    • Health/Employee Benefits
    • Insurance & Financial Fraud
    • INN Magazine
    • Insiders Only
    • Life Insurance News
    • Newswires
    • Property and Casualty
    • Regulation News
    • Sponsored Articles
    • Washington Wire
    • Videos
    • ———
    • About
    • Meet our Editorial Staff
    • Advertise
    • Contact
    • Newsletters
  • Exclusives
  • NewsWires
  • Magazine
  • Newsletters
Sign in or register to be an INNsider.
  • AdvisorNews
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Exclusives
  • INN Magazine
  • Insurtech
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Video
  • Washington Wire
  • Life Insurance
  • Annuities
  • Advisor
  • Health/Benefits
  • Property & Casualty
  • Insurtech
  • About
  • Advertise
  • Contact
  • Editorial Staff

Get Social

  • Facebook
  • X
  • LinkedIn
Newswires
Newswires RSS Get our newsletter
Order Prints
May 1, 2023 Newswires
Share
Share
Post
Email

AFLAC INC – 10-Q – Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&A)

Edgar Glimpses

FORWARD-LOOKING INFORMATION


The Private Securities Litigation Reform Act of 1995 provides a safe harbor to
encourage companies to provide prospective information, so long as those
informational statements are identified as forward-looking and are accompanied
by meaningful cautionary statements identifying important factors that could
cause actual results to differ materially from those included in the
forward-looking statements. Aflac Incorporated (the Parent Company) and its
subsidiaries (collectively with the Parent Company, the Company) desire to take
advantage of these provisions. This report contains cautionary statements
identifying important factors that could cause actual results to differ
materially from those projected herein, and in any other statements made by
Company officials in communications with the financial community and contained
in documents filed with the Securities and Exchange Commission (SEC).
Forward-looking statements are not based on historical information and relate to
future operations, strategies, financial results or other developments.
Furthermore, forward-looking information is subject to numerous assumptions,
risks and uncertainties. In particular, statements containing words such as the
ones listed below or similar words, as well as specific projections of future
results, generally qualify as forward-looking. The Company undertakes no
obligation to update such forward-looking statements.

             • expect    • anticipate   • believe     • goal      • objective
             • may       • should       • estimate    • intends   • projects
             • will      • assumes      • potential   • target    • outlook

The Company cautions readers that the following factors, in addition to other
factors mentioned from time to time, could cause actual results to differ
materially from those contemplated by the forward-looking statements:


•difficult conditions in global capital markets and the economy, including
inflation and the continued effects caused by COVID-19
•defaults and credit downgrades of investments
•global fluctuations in interest rates and exposure to significant interest rate
risk
•concentration of business in Japan
•limited availability of acceptable yen-denominated investments
•foreign currency fluctuations in the yen/dollar exchange rate
•differing interpretations applied to investment valuations
•significant valuation judgments in determination of expected credit losses
recorded on the Company's investments
•decreases in the Company's financial strength or debt ratings
•decline in creditworthiness of other financial institutions
•concentration of the Company's investments in any particular single-issuer or
sector
•major public health issues, including COVID-19 and any resulting or
coincidental economic effects, on the Company's business and financial results
•the Company's ability to attract and retain qualified sales associates,
brokers, employees, and distribution partners
•deviations in actual experience from pricing and reserving assumptions
•ability to continue to develop and implement improvements in information
technology systems and on successful execution of revenue growth and expense
management initiatives
•interruption in telecommunication, information technology and other operational
systems, or a failure to maintain the security, confidentiality or privacy of
sensitive data residing on such systems
•subsidiaries' ability to pay dividends to the Parent Company
•inherent limitations to risk management policies and procedures
•operational risks of third party vendors
•tax rates applicable to the Company may change
•failure to comply with restrictions on policyholder privacy and information
security
•extensive regulation and changes in law or regulation by governmental
authorities
•competitive environment and ability to anticipate and respond to market trends
•catastrophic events, including, but not limited to, as a result of climate
change, epidemics, pandemics (such as COVID-19), tornadoes, hurricanes,
earthquakes, tsunamis, war or other military action, terrorism or other acts of
violence, and damage incidental to such events
•ability to protect the Aflac brand and the Company's reputation
•ability to effectively manage key executive succession
•changes in accounting standards
•level and outcome of litigation
•allegations or determinations of worker misclassification in the United States
                                       75
--------------------------------------------------------------------------------

                                 MD&A OVERVIEW

MD&A is intended to inform the reader about matters affecting the financial
condition and results of operations of Aflac Incorporated and its subsidiaries
for the three-month periods ended March 31, 2023 and 2022, respectively. Results
of operations for interim periods are not necessarily indicative of results for
the entire year. As a result, the following discussion should be read in
conjunction with the consolidated financial statements and notes that are
included in the Company's annual report on Form 10-K for the year ended
December 31, 2022 (2022 Annual Report). In this MD&A, amounts may not foot due
to rounding.

This MD&A is divided into the following sections:

                                                                Page
                   Executive Summary                            77
                   Results of Operations                        78
                   Investments                                  92
                   Hedging Activities                           96
                   Deferred Policy Acquisition Costs            99
                   Policy Liabilities                          100
                   Benefit Plans                               100
                   Policyholder Protection                     100
                   Liquidity and Capital Resources             100
                   Critical Accounting Estimates               105



                                       76
--------------------------------------------------------------------------------

                               EXECUTIVE SUMMARY

Company Overview


Aflac Incorporated (the Parent Company) and its subsidiaries (collectively, the
Company) provide financial protection to millions of policyholders and customers
in Japan and the U.S. The Company's principal business is supplemental health
and life insurance products with the goal to provide customers the best value in
supplemental insurance products in the United States (U.S.) and Japan. The
Company's insurance business consists of two reporting segments: Aflac Japan and
Aflac U.S. The Parent Company's primary insurance subsidiaries are Aflac Life
Insurance Japan Ltd. in Japan (Aflac Japan) and American Family Life Assurance
Company of Columbus (Aflac); Continental American Insurance Company (CAIC),
branded as Aflac Group Insurance (AGI); American Family Life Assurance Company
of New York (Aflac New York); Tier One Insurance Company (TOIC) and Aflac
Benefits Solutions, Inc. (ABS), which provides a platform for Aflac Dental and
Vision in the U.S. (collectively, Aflac U.S.). The Parent Company, other
operating business units that are not individually reportable, and business
activities, including reinsurance activities, not included in Aflac Japan or
Aflac U.S. are included in Corporate and other.

In 2022, the Company established Aflac Re Bermuda Ltd. (Aflac Re), a Bermuda
domiciled insurer that reinsures certain policies issued by ALIJ. Aflac Re is
subject to regulation in Bermuda, where the Bermuda Monetary Authority (BMA) has
broad administrative powers relating to granting and revoking licenses to
transact reinsurance business, approval of specific reinsurance transactions,
capital requirements and solvency standards, limitations on dividends to
shareholders, the nature of and limitations on investments, and the filing of
financial statements in accordance with prescribed or permitted accounting
practices. Financial results from Aflac Re are included in Corporate and other.

Performance Highlights


Total revenues were $4.8 billion in the first three months of 2023, compared
with $5.2 billion in the first three months of 2022. Net earnings were $1.2
billion, or $1.94 per diluted share in the first three months of 2023, compared
with $1.0 billion, or $1.60 per diluted share, in the first three months of
2022.

Results in the first quarter of 2023 included pretax net investment gains of
$123 million, compared with pretax net investment gains of $122 million in the
first three months of 2022. Net investment gains in the first three months of
2023 included an increase in credit loss allowances of $30 million; $99 million
of net gains from certain derivative and foreign currency gains or losses; $3
million of net losses on equity securities; and $57 million of net gains from
sales and redemptions.

The average yen/dollar exchange rate(1) for the three-month period ended
March 31, 2023 was 132.30, or 12.2% weaker than the average yen/dollar exchange
rate(1) of 116.18 for the same period in 2022.


Adjusted earnings(2) in the first quarter of 2023 were $1.0 billion, or $1.55
per diluted share, compared with $942 million, or $1.44 per diluted share, in
the first quarter of 2022. The weaker yen/dollar exchange rate negatively
impacted adjusted earnings per diluted share by $.07.

Total investments and cash at March 31, 2023 were $120.5 billion, compared with
$117.4 billion at December 31, 2022. In the first quarter of 2023, Aflac
Incorporated repurchased $700 million, or 10.3 million of its common shares. At
March 31, 2023, the Company had 106.3 million remaining shares authorized for
repurchase.

Shareholders' equity was $19.8 billion, or $32.65 per share, at March 31, 2023,
compared with $20.1 billion, or $32.73 per share, at December 31, 2022.
Shareholders' equity at March 31, 2023 included a cumulative decrease of $4.9
billion from the effect of changes in discount rate assumptions on insurance
contracts, driven by the adoption of the new accounting guidance for
long-duration insurance contracts, compared with a corresponding cumulative
decrease of $2.1 billion at December 31, 2022, and a net unrealized gain on
investment securities and derivatives of $1.3 billion, compared with a net
unrealized loss of $729 million at December 31, 2022. Shareholders' equity at
March 31, 2023 also included an unrealized foreign currency translation loss of
$3.6 billion, compared with an unrealized foreign currency translation loss of
$3.6 billion at December 31, 2022. The annualized return on average
shareholders' equity in the first quarter of 2023 was 23.8%.

Shareholders' equity excluding accumulated other comprehensive income (AOCI)(2)
(adjusted book value) was $27.1 billion, or $44.66 per share at March 31, 2023,
compared with $26.6 billion, or $43.18 per share, at December 31, 2022. The
annualized adjusted return on equity (ROE) excluding foreign currency impact(2)
in the first quarter of 2023 was 14.8%.

(1) Yen/U.S. dollar exchange rates are based on the published MUFG Bank, Ltd.
telegraphic transfer middle rate (TTM).
(2) See the Results of Operations section of this MD&A for a definition of this
non-U.S. GAAP financial measure.
                                       77
--------------------------------------------------------------------------------

                             RESULTS OF OPERATIONS

The Company earns its revenues principally from insurance premiums and
investments. The Company's operating expenses primarily consist of insurance
benefits provided and reserves established for anticipated future insurance
benefits, general business expenses, commissions and other costs of selling and
servicing its products. Profitability for the Company depends principally on its
ability to price its insurance products at a level that enables the Company to
earn a margin over the costs associated with providing benefits and
administering those products. Profitability also depends on, among other items,
actuarial and policyholder behavior experience on insurance products, and the
Company's ability to attract and retain customer assets, generate and maintain
favorable investment results, effectively deploy capital and utilize tax
capacity, and manage expenses.

This document includes references to the Company's financial performance
measures which are not calculated in accordance with United States generally
accepted accounting principles (U.S. GAAP) (non-U.S. GAAP). The financial
measures exclude items that the Company believes may obscure the underlying
fundamentals and trends in insurance operations because they tend to be driven
by general economic conditions and events or related to infrequent activities
not directly associated with insurance operations.

Due to the size of Aflac Japan, where the functional currency is the Japanese
yen, fluctuations in the yen/dollar exchange rate can have a significant effect
on reported results. In periods when the yen weakens, translating yen into
dollars results in fewer dollars being reported. When the yen strengthens,
translating yen into dollars results in more dollars being reported.
Consequently, yen weakening has the effect of suppressing current period results
in relation to the comparable prior period, while yen strengthening has the
effect of magnifying current period results in relation to the comparable prior
period. A significant portion of the Company's business is conducted in yen and
never converted into dollars but translated into dollars for U.S. GAAP reporting
purposes, which results in foreign currency impact to earnings, cash flows and
book value on a U.S. GAAP basis. Management evaluates the Company's financial
performance both including and excluding the impact of foreign currency
translation to monitor, respectively, cumulative currency impacts and the
currency-neutral operating performance over time. The average yen/dollar
exchange rate is based on the published MUFG Bank, Ltd. telegraphic transfer
middle rate (TTM).

The Company defines the non-U.S. GAAP financial measures included in this
document as follows:


•Adjusted earnings are adjusted revenues less benefits and adjusted expenses.
Adjusted earnings per share (basic or diluted) are the adjusted earnings for the
period divided by the weighted average outstanding shares (basic or diluted) for
the period presented. The adjustments to both revenues and expenses account for
certain items that cannot be predicted or that are outside management's control.
Adjusted revenues are U.S. GAAP total revenues excluding adjusted net investment
gains and losses. Adjusted expenses are U.S. GAAP total acquisition and
operating expenses including the impact of interest cash flows from derivatives
associated with notes payable but excluding any nonrecurring or other items not
associated with the normal course of the Company's insurance operations and that
do not reflect the Company's underlying business performance. Management uses
adjusted earnings and adjusted earnings per diluted share to evaluate the
financial performance of the Company's insurance operations on a consolidated
basis and believes that a presentation of these financial measures is vitally
important to an understanding of the underlying profitability drivers and trends
of the Company's insurance business. The most comparable U.S. GAAP financial
measures for adjusted earnings and adjusted earnings per share (basic or
diluted) are net earnings and net earnings per share, respectively.

•Adjusted net investment gains and losses are net investment gains and losses
adjusted for i) amortized hedge cost/income related to foreign currency exposure
management strategies and certain derivative activity, ii) net interest cash
flows from foreign currency and interest rate derivatives associated with
certain investment strategies, which are both reclassified to net investment
income, and iii) the impact of interest cash flows from derivatives associated
with notes payable, which is reclassified to interest expense as a component of
total adjusted expenses. The Company considers adjusted net investment gains and
losses important as it represents the remainder amount that is considered
outside management's control, while excluding the components that are within
management's control and are accordingly reclassified to net investment income
and interest expense. The most comparable U.S. GAAP financial measure for
adjusted net investment gains and losses is net investment gains and losses.

•Amortized hedge costs/income represent costs/income incurred or recognized as a
result of using foreign currency derivatives to hedge certain foreign exchange
risks in the Company's Japan segment or in Corporate and other. These amortized
hedge costs/ income are estimated at the inception of the derivatives based on
the specific terms of each contract and are recognized on a straight-line basis
over the term of the hedge. The Company believes that amortized hedge
costs/income measure the periodic currency risk management costs/
                                       78
--------------------------------------------------------------------------------

income related to hedging certain foreign currency exchange risks and are an
important component of net investment income. There is no comparable U.S. GAAP
financial measure for amortized hedge costs/ income.

•Adjusted earnings excluding current period foreign currency impact are computed
using the average foreign currency exchange rate for the comparable prior-year
period, which eliminates fluctuations driven solely by foreign currency exchange
rate changes. Adjusted earnings per diluted share excluding current period
foreign currency impact is adjusted earnings excluding current period foreign
currency impact divided by the weighted average outstanding diluted shares for
the period presented. The Company considers adjusted earnings excluding current
period foreign currency impact and adjusted earnings per diluted share excluding
current period foreign currency impact important because a significant portion
of the Company's business is conducted in Japan and foreign exchange rates are
outside management's control; therefore, the Company believes it is important to
understand the impact of translating foreign currency (primarily Japanese yen)
into U.S. dollars. The most comparable U.S. GAAP financial measures for adjusted
earnings excluding current period foreign currency impact and adjusted earnings
per diluted share excluding current period foreign currency impact are net
earnings and net earnings per share, respectively.

•Adjusted book value is the U.S. GAAP book value (representing total
shareholders' equity), less AOCI as recorded on the U.S. GAAP balance sheet.
Adjusted book value per common share is adjusted book value at the period end
divided by the ending outstanding common shares for the period presented. The
Company considers adjusted book value and adjusted book value per common share
important as they exclude AOCI, which fluctuates due to market movements that
are outside management's control. The most comparable U.S. GAAP financial
measures for adjusted book value and adjusted book value per common share are
total book value and total book value per common share, respectively.

•Adjusted return on equity excluding foreign currency impact is adjusted
earnings excluding the current period foreign currency impact divided by average
shareholders' equity, excluding AOCI. The Company considers adjusted return on
equity excluding foreign currency impact important as it excludes changes in
foreign currency and components of AOCI, which fluctuate due to market movements
that are outside management's control. The most comparable U.S. GAAP financial
measure for adjusted return on equity excluding foreign currency impact is ROE
as determined using net earnings and average total shareholders' equity.

•U.S. dollar-denominated investment income excluding foreign currency impact
represents amounts excluding foreign currency impact on U.S. dollar-denominated
investment income using the average foreign currency exchange rate for the
comparable prior year period. The Company considers U.S. dollar-denominated
investment income excluding foreign currency impact important as it eliminates
the impact of foreign currency changes on the Aflac Japan segment results, which
are outside management's control. The most comparable U.S. GAAP financial
measure for U.S. dollar-denominated investment income excluding foreign currency
impact is the corresponding net investment income amount from the U.S. dollar
denominated investments translated to yen.

                                       79
--------------------------------------------------------------------------------

The following table is a reconciliation of items impacting adjusted earnings and
adjusted earnings per diluted share to the most directly comparable U.S. GAAP
financial measures of net earnings and net earnings per diluted share,
respectively.

              Reconciliation of Net Earnings to Adjusted Earnings

                                                                       In Millions                  Per Diluted Share
                                                                      

Three Months Ended March 31,

                                                                                               2023               2022            2023            2022
Net earnings                                                                               $    1,188          $ 1,047          $ 1.94          $ 1.60
Items impacting net earnings:
Adjusted net investment (gains) losses (1)                                                       (209)            (134)           (.34)           (.21)
Other and non-recurring (income) loss                                                               0                1             .00             .00
Income tax (benefit) expense on items excluded from
adjusted earning                                                                                  (26)              28            (.04)            .04

Adjusted earnings                                                                                 953              942            1.55            1.44
Current period foreign currency impact (2)                                                         41                 N/A          .07                

N/A

Adjusted earnings excluding current period foreign
currency impact

                                                                            $      994          $   942          $ 1.62          $ 1.44


(1) See reconciliation of net investment (gains) losses to adjusted net
investment (gains) losses below.
(2) Prior period foreign currency impact reflected as "N/A" to isolate change
for current period only.
Prior-year amounts have been adjusted for the adoption of accounting guidance on
January 1, 2023 related to accounting for long-duration insurance contracts.

Reconciling Items

Net Investment Gains and Losses


   Reconciliation of Net Investment (Gains) Losses to Adjusted Net Investment
                                 (Gains) Losses

                                                                             Three Months
                                                                           Ended March 31,
(In millions)                                                                       2023             2022
Net investment (gains) losses                                                    $  (123)         $  (122)
Items impacting net investment (gains) losses:
Amortized hedge costs                                                                (58)             (26)
Amortized hedge income                                                                29               11

Net interest cash flows from derivatives associated

 with certain investment strategies                                                  (69)              (9)

Interest rate component of the change in fair value

 of foreign currency swaps on notes payable                                           12               13
Adjusted net investment (gains) losses                                      

$ (209) $ (134)




The Company's investment strategy is to invest primarily in fixed maturity
securities to provide a reliable stream of investment income, which is one of
the drivers of the Company's profitability. This investment strategy
incorporates asset-liability matching (ALM) to align the expected cash flows of
the portfolio to the needs of the Company's liability structure. The Company
does not purchase securities with the intent of generating investment gains or
losses. However, investment gains and losses may be realized as a result of
changes in the financial markets and the creditworthiness of specific issuers,
tax planning strategies, and/or general portfolio management and rebalancing.
The realization of investment gains and losses is independent of the
underwriting and administration of the Company's insurance products.

Net investment gains and losses excluded from adjusted earnings include the
following:


•Securities Transactions
•Credit Losses
•Changes in the Fair Value of Equity Securities
•Certain Derivative and Foreign Currency Activities.

                                       80
--------------------------------------------------------------------------------

Securities Transactions, Credit Losses and Changes in the Fair Value of Equity
Securities


Securities transactions include gains and losses from sales and redemptions of
investments where the amount received is different from the amortized cost of
the investment. Credit losses include losses for held-to-maturity fixed maturity
securities, available-for-sale fixed maturity securities, loan receivables, loan
commitments and reinsurance recoverables. Changes in the fair value of equity
securities are the result of gains or losses driven by fluctuations in market
prices.

Certain Derivative and Foreign Currency Activities

The Company's derivative activities include:


•foreign currency forwards and options used in hedging foreign exchange risk on
U.S. dollar-denominated investments in Aflac Japan's portfolio, with options
used on a standalone basis and/or in a collar strategy;

•foreign currency forwards and options used to economically hedge certain
portions of forecasted cash flows denominated in yen and hedge the Company's
long term exposure to a weakening yen;

•cross-currency interest rate swaps, also referred to as foreign currency swaps,
associated with certain senior notes and subordinated debentures;

•foreign currency swaps that are associated with variable interest entity (VIE)
bond purchase commitments, and investments in special-purpose entities,
including VIEs where the Company is the primary beneficiary;

•interest rate swaps used to economically hedge interest rate fluctuations in
certain variable-rate investments;

•interest rate swaptions used to hedge changes in the fair value associated with
interest rate fluctuations for certain U.S. dollar-denominated
available-for-sale fixed-maturity securities; and

•bond purchase commitments at the inception of investments in consolidated VIEs.


Gains and losses are recognized as a result of valuing these derivatives, net of
the effects of hedge accounting. The Company also excludes from adjusted
earnings the accounting impacts of remeasurement associated with changes in the
foreign currency exchange rate.

For additional information regarding net investment gains and losses, including
details of reported amounts for the periods presented, see Notes 3 and 4 of the
Notes to the Consolidated Financial Statements.

Other and Non-recurring Items


The U.S. insurance industry has a policyholder protection system that provides
funds for the policyholders of insolvent insurers. The system can result in
periodic charges to the Company as a result of insolvencies/bankruptcies that
occur with other companies in the life insurance industry. Some states permit
member insurers to recover assessments paid through full or partial premium tax
offsets. These charges neither relate to the ordinary course of the Company's
business nor reflect the Company's underlying business performance, but result
from external situations not controlled by the Company. The Company excludes any
charges associated with U.S. guaranty fund assessments and the corresponding tax
benefit or expense from adjusted earnings.

In Japan, the government also requires the insurance industry to contribute to a
policyholder protection corporation that provides funds for the policyholders of
insolvent insurers; however, these costs are calculated and administered
differently than in the U.S. In Japan, these costs are not directly related to
specific insolvencies or bankruptcies, but are rather a regular operational cost
for an insurance company. Based on this structure, the Company does not remove
the Japan policyholder protection expenses from adjusted earnings.

The Company considers the costs associated with the early redemption of its debt
to be unrelated to the underlying fundamentals and trends in its insurance
operations. Additionally, these costs are driven by changes in interest rates
subsequent to the issuance of the debt, and the Company considers these interest
rate changes to represent economic conditions not directly associated with its
insurance operations.
                                       81
--------------------------------------------------------------------------------

Income Taxes


The Company's combined U.S. and Japanese effective income tax rate on pretax
earnings was 11.5% for the three-month period ended March 31, 2023, compared
with 19.1% for the same period in 2022. The combined effective tax rate differs
from the U.S. statutory rate primarily due to historic and solar tax credits and
the exclusion of foreign currency translation gains and losses held in the
Delaware Statutory Trust. For additional information, see the Critical
Accounting Estimates - Income Taxes section of Item 7. MD&A in the 2022 Annual
Report.

The Company expects that its effective tax rate on adjusted earnings for future
periods will be approximately 20%. The effective tax rate continues to be
subject to future tax law changes both in the U.S. and in foreign jurisdictions.
See the risk factor entitled "Tax rates applicable to the Company may change" in
Item 1A. Risk Factors of the 2022 Annual Report for more information.

Foreign Currency Translation


Aflac Japan's premiums and a significant portion of its investment income are
received in yen, and its claims and most expenses are paid in yen. Aflac Japan
purchases yen-denominated assets and U.S. dollar-denominated assets, which may
be hedged to yen, to support yen-denominated policy liabilities. Yen-denominated
income statement accounts are translated to U.S. dollars using the weighted
average Japanese yen/U.S. dollar foreign exchange rate for the reporting period,
except realized gains and losses on securities transactions which are translated
at the exchange rate on the trade date of each transaction. Yen-denominated
balance sheet accounts are translated to U.S. dollars using the spot Japanese
yen/U.S. dollar foreign exchange rate at the end of the reporting period.

                        RESULTS OF OPERATIONS BY SEGMENT

U.S. GAAP financial reporting requires that a company report financial and
descriptive information about operating segments in its annual and interim
period financial statements. Furthermore, the Company is required to report a
measure of segment profit or loss, certain revenue and expense items, and
segment assets. The Company's insurance business consists of two segments: Aflac
Japan and Aflac U.S. Aflac Japan is the principal contributor to consolidated
earnings. In addition, the Parent Company, other business units that are not
individually reportable, and business activities, including reinsurance
activities, not included in Aflac Japan or Aflac U.S. are included in Corporate
and other. See Item 1. Business in the 2022 Annual Report for a summary of each
segment's products and distribution channels.

Consistent with U.S. GAAP guidance for segment reporting, pretax adjusted
earnings is the Company's U.S. GAAP measure of segment performance. The Company
believes that a presentation of this measure is vitally important to an
understanding of the underlying profitability drivers and trends of its
business. Additional performance measures used to evaluate the financial
condition and performance of the Company's segments are listed below.


•Operating Ratios
•New Annualized Premium Sales
•New Money Yield
•Return on Average Invested Assets
•Average Weekly Producer
•Premium Persistency

For additional information on the Company's performance measures included in
this MD&A, see the Glossary of Selected Terms found directly following Part II.
Other Information. See Note 2 of the Notes to the Consolidated Financial
Statements for the reconciliation of segment results to the Company's
consolidated U.S. GAAP results and additional information.
                                       82
--------------------------------------------------------------------------------

AFLAC JAPAN SEGMENT

Aflac Japan Pretax Adjusted Earnings


Changes in Aflac Japan's pretax adjusted earnings and profit margins are
primarily affected by morbidity, mortality, expenses, persistency and investment
yields. The following table presents a summary of operating results for Aflac
Japan.

                    Aflac Japan Summary of Operating Results

                                                                                        Three Months
                                                                                      Ended March 31,
(In millions)                                                                                  2023             2022
Net earned premiums                                                                         $ 2,170          $ 2,625
Net investment income: (1)
Yen-denominated investment income                                                               263              299
U.S. dollar-denominated investment income                                                       407              406
Net investment income                                                                           669              705

Amortized hedge costs related to certain foreign currency exposure management
strategies

                                                                                      (58)              26
Adjusted net investment income                                                                  611              680
Other income (loss)                                                                               9                9
Total adjusted revenues                                                                       2,790            3,314
Benefits and claims:
Benefits and claims, excluding reserve remeasurement                                          1,466            1,793
Reserve remeasurement (gains) losses                                                            (13)             (14)
Total benefits and claims, net                                                                1,453            1,779
Adjusted expenses:
Amortization of deferred policy acquisition costs                                                85               94
Insurance commissions                                                                           138              161
Insurance and other expenses                                                                    326              409
Total adjusted expenses                                                                         549              664
Total benefits and adjusted expenses                                                          2,002            2,443
      Pretax adjusted earnings                                                              $   788          $   870
Weighted-average yen/dollar exchange rate                                                    132.30           116.18


                                                                                        In Dollars                                                                          In Yen
                                                                       Three Months Ended
Percentage change over                                                     March 31,                                       Three Months Ended March 31,
 previous period:                                                                2023                  2022                                                        2023               2022
Net earned premiums                                                                (17.3) %             (11.5) %                                                    (5.9) %             (2.8) %
Adjusted net investment income                                                     (10.1)                (3.6)                                                       2.4                 5.9
Total adjusted revenues                                                            (15.8)               (10.0)                                                      (4.1)               (1.2)
Pretax adjusted earnings                                                            (9.4)                (5.0)                                                       3.2                 4.7


(1) Net interest cash flows from derivatives associated with certain investment
strategies of $(62) and $(10) for the three-month periods ended March 31, 2023
and 2022, respectively, have been reclassified from net investment gains
(losses) and included in adjusted earnings as a component of net investment
income.
Prior-year amounts have been adjusted for the adoption of accounting guidance on
January 1, 2023 related to accounting for long-duration insurance contracts.

In the three-month period ended March 31, 2023, Aflac Japan's net earned
premiums decreased, in yen terms, mainly due to limited-pay products reaching
premium paid-up status and the implementation of the Aflac Re global reinsurance
strategy. Adjusted net investment income, in yen terms, increased in the
three-month period ended March 31, 2023, primarily due to the impact of foreign
exchange on U.S. dollar-denominated investments offset by higher hedge costs.
The increase in pretax adjusted earnings in yen for the three-month period ended
March 31, 2023 was primarily due to a decrease in total benefits and adjusted
expenses.

Annualized premiums in force decreased 4.8% to ¥1.28 trillion as of March 31,
2023
, compared with ¥1.35 trillion as of March 31, 2022. The decrease in
annualized premiums in force in yen was driven primarily by limited-pay products

                                       83
--------------------------------------------------------------------------------

reaching premium paid-up status and lower sales. Annualized premiums in force,
translated into dollars at respective period-end exchange rates, were $9.6
billion at March 31, 2023, compared with $11.0 billion at March 31, 2022. As of
March 31, 2023, Aflac Japan exceeded 23 million individual policies in force in
Japan, with more than 14 million cancer policies in force in Japan.

Aflac Japan's investment portfolios include U.S. dollar-denominated securities
and reverse-dual currency securities (yen-denominated debt securities with
dollar coupon payments). In years when the yen strengthens in relation to the
dollar, translating Aflac Japan's U.S. dollar-denominated investment income into
yen lowers growth rates for net investment income, total adjusted revenues, and
pretax adjusted earnings in yen terms. In years when the yen weakens,
translating U.S. dollar-denominated investment income into yen magnifies growth
rates for net investment income, total adjusted revenues, and pretax adjusted
earnings in yen terms.

The following table illustrates the effect of translating Aflac Japan's U.S.
dollar-denominated investment income and related items into yen by comparing
certain segment results with those that would have been reported had foreign
currency exchange rates remained unchanged from the comparable period in the
prior year. Amounts excluding foreign currency impact on U.S. dollar-denominated
investment income were determined using the average foreign currency exchange
rate for the comparable prior year period. See non-U.S. GAAP financial measures
defined above.

              Aflac Japan Percentage Changes Over Previous Period
                            (Yen Operating Results)
                        For the Periods Ended March 31,

                                                                                   Including Foreign                                                            Excluding Foreign
                                                                                   Currency Changes                                                             Currency Changes
                                                                     Three Months                                              Three Months
                                                                            2023                     2022                                                     2023                  2022
Adjusted net investment income                                           2.4     %                   5.9    %                                              (5.9)   %               .3    %
Total adjusted revenues                                                 (4.1)                       (1.2)                                                  (5.8)                 (2.3)
Pretax adjusted earnings                                                 3.2                         4.7                                                   (3.0)                   .5

Prior-year amounts have been adjusted for the adoption of accounting guidance on
January 1, 2023 related to accounting for long-duration insurance contracts.

The following table presents a summary of operating ratios in yen terms for Aflac Japan.


                                                                                     Three Months Ended March 31,
Ratios to total adjusted revenues:                                                                                     2023                    2022
Total benefits and claims, net                                                                                      52.1         %          53.7    %
Adjusted expenses:
Amortization of deferred policy acquisition costs                                                                    3.1                     2.8
Insurance commissions                                                                                                4.9                     4.8
Insurance and other expenses                                                                                        11.7                    12.4
Total adjusted expenses                                                                                             19.7                    20.0
Pretax adjusted earnings                                                                                            28.2                    26.2
Ratios to total premiums:
Total benefits and claims, net                                                                                      67.0    %               67.9    %
Adjusted expenses:
Amortization of deferred policy acquisition costs                                                                    3.9                     3.6


Prior-year amounts have been adjusted for the adoption of accounting guidance on
January 1, 2023 related to accounting for long-duration insurance contracts.


In the three-month period ended March 31, 2023, the total benefits and claims
ratio to total premiums decreased, compared with the same period in the prior
year, primarily due to a decrease in the third sector benefit ratio due to
favorable experience and the continued change in the mix of first and third
sector business. In the three-month period ended March 31, 2023, the total
adjusted expense ratio decreased slightly, compared with the same period in the
prior year, reflecting the decrease in total adjusted revenues and an offsetting
decrease in total adjusted expenses due to expense control efforts as well as
the reinsurance transaction with Aflac Re. In total, the pretax adjusted profit
margin
                                       84
--------------------------------------------------------------------------------

increased in the three-month period ended March 31, 2023 primarily due to a
lower benefit ratio and a lower expense ratio and an offsetting decrease in
total adjusted revenues.


The following table presents Aflac Japan's premium persistency on a 12-month
rolling basis as of March 31.

                         2023           2022
Premium persistency      93.9     %     94.3     %



Aflac Japan Sales

The following table presents Aflac Japan's new annualized premium sales for the
periods ended March 31.

                                                                               In Dollars                                        In Yen
                                                               Three Months                      Three Months
(In millions of dollars and billions of yen)                          2023           2022                              2023            2022
New annualized premium sales                                        $ 100          $  103                            ¥ 13.2          ¥ 11.9
Increase (decrease) over prior period                                (3.2) %        (22.4) %                           10.8  %        (14.8) %



In 2023, the new annualized premium sales on a yen basis increased, compared
with 2022, due primarily to sales of Aflac Japan's new cancer insurance product
and updated first sector products, all of which were launched in the second half
of 2022. Further, these products were launched at Dai-ichi Life and other
financial institutions in January 2023.

The following table details the contributions to Aflac Japan's new annualized
premium sales by major insurance product for the periods ended March 31.

                                             Three Months
                                                           2023            2022
Cancer                                                     59.9  %         53.0  %
Medical and other health:
Medical                                                    20.8            31.4
Income support                                               .6             1.1
Life insurance:
Traditional life (1)                                        7.3             9.0
WAYS                                                        8.9              .7
Child endowment                                              .6              .3
Other                                                       1.9             4.5
  Total                                                   100.0  %        100.0  %

(1) Includes term and whole life


The foundation of Aflac Japan's product portfolio has been, and continues to be,
third sector products, which include cancer, medical, income support, and
nursing care insurance products. With continued cost pressure on Japan's health
care system, the Company expects the need for third sector products will
continue to rise in the future and that the medical and cancer insurance
products Aflac Japan provides will continue to be an important part of its
product portfolio. Moreover, in November 2022, Aflac Japan refreshed its first
sector savings-type products WAYS and Child Endowment and began to actively
promote sales of these products after having curtailed sales of both products
beginning in 2013. The refreshment of these first sector products position Aflac
Japan for potential future long-term sales opportunities by marketing these
products to a younger demographic as well as potential cross-selling
opportunities of Aflac Japan's third sector products.

Sales of Aflac Japan cancer insurance products in the Japan Post Group channel
experienced a material decline beginning in August 2019. Japan Post Group
resumed proactive sales of cancer insurance policies in April 2021 and Aflac
Japan continues to strengthen the strategic alliance. In April 2023, Japan Post
Group began selling Aflac Japan's new cancer insurance product that was launched
in August 2022. For additional information, see the risk factor entitled "Sales
of the Company's products and services are dependent on its ability to attract,
retain and support a network of qualified sales associates, brokers and
employees in the U.S. and sales associates and other distribution partners in
Japan," in Item 1A. Risk Factors in the 2022 Annual Report.
                                       85
--------------------------------------------------------------------------------


Aflac Japan continues to promote digital and web-based sales to groups and use
of its system that enables smart device-based insurance application by allowing
the customer and an Aflac Japan operator to see the same screen through their
smart devices. Further, Aflac Japan continues to utilize its virtual sales tool
that enables online consultations and policy applications to be completed
entirely online.

The following table details the contributions to Aflac Japan's new annualized
premium sales by agency type for the three-month periods ended March 31.


                                         2023         2022
Independent corporate and individual     50.9  %      48.9  %
Affiliated corporate (1)                 45.4         46.5
Bank                                      3.7          4.6
Total                                   100.0  %     100.0  %

(1) Includes Japan Post Group, Dai-ichi Life and Daido Life


During the three-month period ended March 31, 2023, Aflac Japan recruited 4 new
sales agencies. At March 31, 2023, Aflac Japan was represented by approximately
7,300 sales agencies, with approximately 110,000 licensed sales associates
employed by those agencies. The number of sales agencies has declined in recent
years due to Aflac Japan's focus on supporting agencies with strong management
frameworks, high productivity and more producing agents.

At March 31, 2023, Aflac Japan had agreements to sell its products at 359 banks,
approximately 90% of the total number of banks in Japan.

Aflac Japan Investments


The level of investment income in yen is affected by available cash flow from
operations, the timing of investing the cash flow, yields on new investments,
the effect of yen/dollar exchange rates on U.S. dollar-denominated investment
income, and other factors.

As part of the Company's portfolio management and asset allocation process,
Aflac Japan invests in yen and U.S. dollar-denominated investments.
Yen-denominated investments primarily consist of JGBs, public and private fixed
maturity securities and public equity securities. Aflac Japan's U.S.
dollar-denominated investments include fixed maturity investments and growth
assets, including alternative investments in limited partnerships or similar
investment vehicles. Aflac Japan has been investing in both publicly traded and
privately originated U.S. dollar-denominated investment-grade and
below-investment-grade fixed maturity securities and loan receivables, and has
entered into foreign currency forwards and options to hedge the currency risk on
the fair value of a portion of the U.S. dollar investments.

                                       86
--------------------------------------------------------------------------------

The following table details the investment purchases for Aflac Japan.

                                                        Three Months Ended March 31,
(In millions)                                                                    2023         2022
Yen-denominated:
 Fixed maturity securities:
   Japan government and agencies                                               $   151      $     0
   Private placements                                                              273          307
   Other fixed maturity securities                                                  77           17
 Equity securities                                                                 123           91
 Other investments                                                                   6            3
    Total yen-denominated                                                      $   630      $   418

U.S. dollar-denominated:
 Fixed maturity securities:
   Other fixed maturity securities                                             $   376      $    85

   Collateralized loan obligations                                                   0           67

Commercial mortgage and other loans:

   Transitional real estate loans                                                   53          507

   Middle market loans                                                             150          311
 Other investments                                                                 137           48
    Total U.S. dollar-denominated                                              $   716      $ 1,018
      Total Aflac Japan purchases                                              $ 1,346      $ 1,436


See the Investments section of this MD&A for further discussion of these
investment programs, and see Notes 3 and 4 of the Notes to the Consolidated
Financial Statements and Notes 1, 3 and 4 of the Notes to the Consolidated
Financial Statements in the 2022 Annual Report for more information regarding
loans and loan receivables.

The following table presents the results of Aflac Japan's investment yields for
the periods ended March 31.

Three Months

                                                                                                             2023                   2022
Total purchases for the period (in millions) (1)                                                       $ 1,203                $ 1,385
New money yield (1),(2)                                                                                   5.18        %          3.90        %
Return on average invested assets (3)                                                                     2.57                   2.54

Portfolio book yield, including U.S. dollar-denominated investments, end
of period (1),(2)

                                                                                         3.13        %          2.62        %


(1) Includes fixed maturity securities, commercial mortgage and other loans,
equity securities, and excludes alternative investments in limited partnerships
(2) Reported on a gross yield basis; excludes investment expenses, external
management fees, and amortized hedge costs
(3) Net of investment expenses and amortized hedge costs, year-to-date number
reflected on a quarterly average basis

The increase in the Aflac Japan new money yield in the three-month period ended
March 31, 2023 was primarily due to increases in U.S. interest rates. See Notes
3, 4 and 5 of the Notes to the Consolidated Financial Statements and the
Investments and Hedging Activities sections of this MD&A for additional
information on the Company's investments and hedging strategies.

AFLAC U.S. SEGMENT

Aflac U.S. Pretax Adjusted Earnings


Changes in Aflac U.S. pretax adjusted earnings and profit margins are primarily
affected by morbidity, mortality, expenses, persistency and investment yields.
The following table presents a summary of operating results for Aflac U.S.
                                       87
--------------------------------------------------------------------------------

                    Aflac U.S. Summary of Operating Results

                                                                                  Three Months
                                                                                Ended March 31,
(In millions)                                                                            2023             2022
Net earned premiums                                                                   $ 1,428          $ 1,413
Adjusted net investment income (1)                                                        197              184
Other income                                                                               35               42
Total adjusted revenues                                                                 1,660            1,639
Benefits and claims:
Benefits and claims, excluding reserve remeasurement                                      691              686
Reserve remeasurement (gains) losses                                                      (40)             (20)
Total benefits and claims                                                                 651              666
Adjusted expenses:
Amortization of deferred policy acquisition costs                                         119              114
Insurance commissions                                                                     142              140
Insurance and other expenses                                                              395              387
Total adjusted expenses                                                                   657              640
Total benefits and adjusted expenses                                                    1,308            1,306
       Pretax adjusted earnings                                                       $   352          $   333
Percentage change over previous period:
Net earned premiums                                                                       1.1    %         (.6)   %
Adjusted net investment income                                                            7.1              4.5
Total adjusted revenues                                                                   1.3               .7
Pretax adjusted earnings                                                                  5.7               .6


(1) Net interest cash flows from derivatives associated with certain investment
strategies of $(7) and $1 for the three-month periods ended March 31, 2023 and
2022, respectively, have been reclassified from net investment gains (losses)
and included in adjusted earnings as a component of net investment income.
Prior-year amounts have been adjusted for the adoption of accounting guidance on
January 1, 2023 related to accounting for long-duration insurance contracts.

In the three-month period ended March 31, 2023, net earned premiums for Aflac
U.S. increased primarily driven by continued investments in growth initiatives.
Adjusted net investment income increased in the three-month period ended
March 31, 2023 primarily due to higher floating rate income due to higher
volumes and rates. The increase in pretax adjusted earnings in the three-month
period ended March 31, 2023 was driven primarily by lower benefits and higher
revenues, partially offset by higher expenses.

Annualized premiums in force increased 1.4% to $6.0 billion at March 31, 2023,
compared with $5.9 billion at March 31, 2022.

                                       88
--------------------------------------------------------------------------------

The following table presents a summary of operating ratios for Aflac U.S.


                                                                                       Three Months Ended March 31,
Ratios to total adjusted revenues:                                                                                       2023                   2022
Total benefits and claims                                                                                             39.2    %              40.7    %
Adjusted expenses:
Amortization of deferred policy acquisition costs                                                                      7.2                    7.0
Insurance commissions                                                                                                  8.6                    8.5
Insurance and other expenses                                                                                          23.8                   23.5
Total adjusted expenses                                                                                               39.6                   39.0
 Pretax adjusted earnings                                                                                             21.2                   20.3
Ratios to total premiums:
Total benefits and claims                                                                                             45.6    %              47.1    %
Adjusted expenses:
Amortization of deferred policy acquisition costs                                                                      8.3                    8.1


Prior-year amounts have been adjusted for the adoption of accounting guidance on
January 1, 2023 related to accounting for long-duration insurance contracts.


For the three-month period ended March 31, 2023, the total benefits and claims
ratio to total premiums decreased compared with the same period in 2022,
reflecting assumption updates in the third quarter of 2022 and reserve
remeasurement gains related to experience. The total adjusted expense ratio
increased in the three-month period ended March 31, 2023, when compared with the
same period in 2022, primarily due to higher planned spending, reflecting
ongoing investments in the U.S. platform and higher DAC amortization associated
with lower persistency. The pretax adjusted profit margin increased in the
three-month period ended March 31, 2023, compared with the same period in 2022,
primarily due to the lower benefit ratio.

The following table presents premium persistency for Aflac U.S. on a 12-month
rolling basis as of March 31.

                         2023           2022
Premium persistency      77.9     %     78.7     %



Aflac U.S. Sales

The following table presents Aflac's U.S. new annualized premium sales for the
periods ended March 31.

                                                       Three Months
(In millions)                                                       2023             2022
New annualized premium sales                                       $ 315          $ 299
Increase (decrease) over prior period                                5.3    

% 19.0 %




New annualized premium sales for accident insurance decreased 1.8%; disability
sales increased 13.8%; critical care insurance sales (including cancer
insurance) increased 1.8%; hospital indemnity insurance sales increased .2%;
dental/vision sales increased 22.7%; and life sales increased 10.3% in the first
quarter of 2023, compared with the first quarter of 2022. The increase in sales
for Aflac U.S. in the first quarter of 2023 reflects continued improvement from
investment in growth initiatives as well as productivity gains.
                                       89
--------------------------------------------------------------------------------

The following table details the contributions to Aflac's U.S. new annualized
premium sales by major insurance product category for the periods ended
March 31.

                                     Three Months
                                                       2023            2022
Accident                                             23.5   %        25.3   %
Disability                                           25.2            23.3
 Critical care(1)                                    20.5            21.2
Hospital indemnity                                   15.9            16.7
Dental/vision                                         6.6             5.6
Life                                                  8.3             7.9
Total                                               100.0     %     100.0     %

(1) Includes cancer, critical illness, and hospital intensive care products



In the first quarter of 2023, the Aflac U.S. sales force included an average of
approximately 6,100 U.S. agents, including brokers, who were actively producing
business on a weekly basis. The Company believes that this average weekly
producer equivalent metric allows sales management to monitor progress and
needs, as well as serve as a leading indicator of future production capacity.

Aflac U.S. Investments

The level of investment income is affected by available cash flow from
operations, the timing of investing the cash flow, yields on new investments,
and other factors.


As part of the Company's portfolio management and asset allocation process,
Aflac U.S. invests in fixed maturity investments and growth assets, including
public equity securities and alternative investments in limited partnerships.
Aflac U.S. has been investing in both publicly traded and privately originated
investment-grade and below-investment-grade fixed maturity securities and loan
receivables.

The following table details the investment purchases for Aflac U.S.


                                                         Three Months Ended 

March 31,

     (In millions)                                                                 2023       2022
     Fixed maturity securities:
        Other fixed maturity securities                                           $ 209      $ 232
        Infrastructure debt                                                           0          9

     Equity securities                                                                0          9
     Commercial mortgage and other loans:
        Transitional real estate loans                                               14        107

        Middle market loans                                                          19        166
     Other investments                                                               15          5
         Total Aflac U.S. Purchases                                               $ 257      $ 528


See Note 3 of the Notes to the Consolidated Financial Statements and Notes 1 and
3 of the Notes to the Consolidated Financial Statements in the 2022 Annual
Report for more information regarding loans and loans receivables.

                                       90
--------------------------------------------------------------------------------

The following table presents the results of Aflac's U.S. investment yields for
the periods ended March 31.


                                                          Three Months
                                                                              2023           2022
Total purchases for period (in millions) (1)                                 $ 242          $ 523
New money yield (1),(2)                                                       7.01     %     4.60     %
Return on average invested assets (3)                                         4.74           4.61
Portfolio book yield, end of period (1),(2)                                 

5.46 % 4.95 %



(1) Includes fixed maturity securities, commercial mortgage and other loans,
equity securities, and excludes alternative investments in limited partnerships
(2) Reported on a gross yield basis; excludes investment expenses and external
management fees
(3) Net of investment expenses, year-to-date number reflected on a quarterly
average basis

The increase in the Aflac U.S. new money yield in the three-month period ended
March 31, 2023 was primarily due to increases in U.S. interest rates. See Notes
3 and 5 of the Notes to the Consolidated Financial Statements and the
Investments section of this MD&A for additional information on the Company's
investments.

CORPORATE AND OTHER

Changes in the pretax adjusted earnings of Corporate and other are primarily
affected by investment income. The following table presents a summary of results
for Corporate and other.

                Corporate and Other Summary of Operating Results

                                                                               Three Months
                                                                              Ended March 31,
(In millions)                                                                          2023            2022
Net earned premiums                                                                  $   91          $   41
Net investment income (loss) (1)                                                          7               4

Amortized hedge income related to certain foreign currency management
strategies

                                                                               29              11
Adjusted net investment income                                                           36              15
Other income                                                                              2              18
Total adjusted revenues                                                                 129              74
Total benefits and claims, net                                                           46              37
Adjusted expenses:
Interest expense                                                                         33              40
Other adjusted expenses                                                                  57              40
Total adjusted expenses                                                                  90              80
Total benefits and adjusted expenses                                                    136             116
Pretax adjusted earnings                                                    

$ (7) $ (42)



(1) The change in value of federal historic rehabilitation and solar investments
in partnerships of $51 and $12 for the three-month periods ended March 31, 2023,
and 2022, respectively, is included as a reduction to net investment income. Tax
credits on these investments of $52 and $16 for the three-month periods ended
March 31, 2023, and 2022, respectively, have been recorded as an income tax
benefit in the consolidated statement of earnings. See Note 3 of the Notes to
the Consolidated Financial Statements for additional information on these
investments.
Prior-year amounts have been adjusted for the adoption of accounting guidance on
January 1, 2023 related to accounting for long-duration insurance contracts.

In the three-month period ended March 31, 2023, total adjusted revenues
increased compared to the same period in 2022 primarily due to higher total
premiums associated with the Aflac Re global reinsurance strategy and an
increase in adjusted net investment income. Total adjusted expenses increased
compared to the same period in 2022 primarily due to expenses associated with
the Aflac Re global reinsurance strategy. These results also reflect the impact
of foreign currency on total net earned premiums and the corresponding benefits.
Pretax adjusted earnings increased in the three-month period ended March 31,
2023 when compared to the same period in 2022 reflecting the increase in total
adjusted revenue, partially offset by higher other adjusted expenses, net
benefits and claims.

The Parent Company invests in partnerships that specialize in rehabilitating
historic structures or the installation of solar equipment in order to receive
federal historic rehabilitation and solar tax credits. These investments are
classified as
                                       91
--------------------------------------------------------------------------------

limited partnerships and included in other investments in the consolidated
balance sheet. The change in value of each investment is recorded as a reduction
to net investment income. Tax credits generated by these investments are
recorded as an income tax benefit in the consolidated statement of earnings.

                                  INVESTMENTS

The Company's investment strategy utilizes disciplined asset and liability
management while seeking long-term risk-adjusted investment returns and the
delivery of stable income within regulatory and capital objectives, and
preserving shareholder value. In attempting to optimally balance these
objectives, the Company seeks to maintain on behalf of Aflac Japan a diversified
portfolio of yen-denominated investment assets, U.S. dollar-denominated
investment portfolio hedged back to yen and a portfolio of unhedged U.S.
dollar-denominated assets. As part of the Company's portfolio management and
asset allocation process, Aflac U.S. invests in fixed maturity investments and
growth assets, including public equity securities and alternative investments in
limited partnerships. Aflac U.S. invests in both publicly traded and privately
originated investment-grade and below-investment-grade fixed maturity securities
and loans. The Company is also a signatory to the Principles for Responsible
Investment, a global framework for incorporating environmental, social and
governance (ESG) considerations into investment and ownership decisions.

For additional information concerning the Company's investments, see Notes 3, 4,
and 5 of the Notes to the Consolidated Financial Statements.

The following tables detail investments by segment.

                        Investment Securities by Segment

                                                                       March 31, 2023
                                                                                    Corporate and
(In millions)                            Aflac Japan            Aflac U.S.              Other                Total
Available for sale, fixed maturity
securities,
  at fair value                        $     61,628           $    12,661           $     3,810           $  78,099
Held to maturity, fixed maturity
securities,
  at amortized cost (1)                      18,936                     0                     0              18,936
Equity securities                               655                    51                   381               1,087
Commercial mortgage and other loans:
Transitional real estate loans (1)            5,277                 1,158                   200               6,635
Commercial mortgage loans (1)                 1,134                   624                     0               1,758
Middle market loans (1)                       4,474                   461                     0               4,935
Other investments:
Policy loans                                    189                    25                     0                 214
Short-term investments (2)                    1,334                   172                 1,055               2,561
Limited partnerships                          2,034                   222                   176               2,432
Other                                             0                    34                     0                  34
Investment in affiliate (3)                       0                   119                  (119)                  0
   Total investments                         95,661                15,527                 5,503             116,691
Cash and cash equivalents                     1,517                   701                 1,591               3,809
       Total investments and cash      $     97,178           $    16,228           $     7,094           $ 120,500


(1) Net of allowance for credit losses
(2) Includes securities lending collateral
(3) For consolidated reporting, Aflac U.S.'s investment in Aflac Re is
eliminated in Corporate and other

                                       92
--------------------------------------------------------------------------------
                                                                      December 31, 2022
                                                                                    Corporate and
(In millions)                            Aflac Japan            Aflac U.S.              Other                Total
Available for sale, fixed maturity
securities,
  at fair value                        $     61,615           $    12,231           $     1,895           $  75,741
Held to maturity, fixed maturity
securities,
  at amortized cost (1)                      19,056                     0                     0              19,056
Equity securities                               650                    51                   390               1,091
Commercial mortgage and other loans:
Transitional real estate loans (1)            5,133                 1,140                   182               6,455
Commercial mortgage loans (1)                 1,269                   729                    15               2,013
Middle market loans (1)                       4,557                   471                     0               5,028
Other investments:
Policy loans                                    190                    24                     0                 214
Short-term investments (2)                      319                   184                 1,029               1,532
Limited partnerships                          1,900                   208                   182               2,290
Other                                             0                    34                     0                  34
Investment in affiliate (3)                       0                   195                  (195)                  0
   Total investments                         94,689                15,267                 3,498             113,454
Cash and cash equivalents                     1,601                   720                 1,622               3,943
       Total investments and cash      $     96,290           $    15,987           $     5,120           $ 117,397


(1) Net of allowance for credit losses
(2) Includes securities lending collateral
(3) For consolidated reporting, Aflac U.S.'s investment in Aflac Re is
eliminated in Corporate and other

The ratings of the Company's securities referenced in the table below are based
on the ratings designations provided by major rating organizations such as
Moody's, Standard & Poor's and Fitch or, if not rated, are determined based on
the Company's internal analysis of such securities. When the ratings issued by
the rating agencies differ, the Company utilizes the second lowest rating when
three or more rating agency ratings are available or the lowest rating when only
two rating agency ratings are available.

The distributions of fixed maturity securities the Company owns, by credit
rating, were as follows:


           Composition of Fixed Maturity Securities by Credit Rating

                              March 31, 2023                                     December 31, 2022
                    Amortized                  Fair                     Amortized                    Fair
                      Cost                     Value                       Cost                      Value
AAA                       1.7  %                    1.6  %                      1.6  %                    1.5  %
AA                        5.3                       5.4                         5.2                       5.3
A                        67.9                      68.0                        68.0                      68.1
BBB                      23.0                      22.8                        23.0                      22.9
BB or lower               2.1                       2.2                         2.2                       2.2
Total                   100.0  %                  100.0  %                    100.0  %                  100.0  %



As of March 31, 2023, the Company's direct and indirect exposure to securities
in its investment portfolio that were guaranteed by third parties was immaterial
both individually and in the aggregate.

                                       93
--------------------------------------------------------------------------------

The following table presents the 10 largest unrealized loss positions in the
Company's portfolio as of March 31, 2023.


                                 Credit            Amortized            

Fair

(In millions)                    Rating              Cost               Value            Unrealized Loss
KLM Royal Dutch Airlines             B                $ 136            $ 103                       $ (33)
GLP Pte Ltd.                        BBB                 112               80                         (32)
Autostrade Per Litalia Spa          BBB                 148              116                         (32)
Prologis LP                          A                  171              141                         (30)
JP Morgan Chase and Co.              A                  200              171                         (29)
Banco de Chile                       A                  150              122                         (28)
Investcorp Capital Limited          BB                  327              306                         (21)
Credit Suisse Group AG              BBB                  75               55                         (20)
Grand City Properties SA            BBB                  56               37                         (19)
Urban Renaissance Agency             A                  183              164                         (19)



Generally, declines in fair values can be a result of changes in interest rates,
yen/dollar exchange rate, and changes in net spreads driven by a broad market
move or a change in the issuer's underlying credit quality. The Company believes
these issuers have the ability to continue making timely payments of principal
and interest. See the Unrealized Investment Gains and Losses section in Note 3
of the Notes to the Consolidated Financial Statements for further discussions of
unrealized losses related to financial institutions and other corporate
investments.

Below-Investment-Grade Securities

The Company's portfolio of below-investment-grade securities includes debt
securities purchased while the issuer was rated investment grade plus other
loans and bonds purchased as part of an allocation to that segment of the
market. The following is the Company's below-investment-grade exposure.


                       Below-Investment-Grade Investments

                                                           March 31, 2023
                                                                                  Unrealized
                                          Par        Amortized        Fair           Gain
(In millions)                            Value        Cost (1)        Value         (Loss)
Investcorp Capital Limited             $   327      $      327      $   306      $      (21)
Pemex Project Funding Master Trust         225             225          228               3
Commerzbank                                187             145          205              60
Telecom Italia SpA                         150             150          183              33
KLM Royal Dutch Airlines                   150             136          103             (33)
Apache Corporation                         138             110          130              20
Howmet Aerospace Inc.                      100              70          101              31
IKB Deutsche Industriebank AG               97              48           77              29
Generalitat de Catalunya                    60              25           60              35
National Gas Co. Trinidad & Tobago          52              50           46              (4)
Other Issuers                               63              64           51             (13)
     Subtotal (2)                        1,549           1,350        1,490             140

High yield corporate bonds                 736             622          668              46
Middle market loans                      4,642           4,454        4,456               2
     Grand Total                       $ 6,927      $    6,426      $ 6,614      $      188


(1) Net of allowance for credit losses
(2) Securities initially purchased as investment grade, but have subsequently
been downgraded to below investment grade

The Company invests in middle market loans primarily to U.S. corporate
borrowers, most of which have below-investment-grade ratings. The objectives of
this program include enhancing the yield on invested assets, achieving further
diversification of credit risk, and mitigating the risk of rising interest rates
and hedge costs through the acquisition of floating rate assets.

                                       94
--------------------------------------------------------------------------------

The Company maintains an allocation to higher yielding corporate bonds within
the Aflac Japan and Aflac U.S. portfolios. Most of these securities were rated
below-investment-grade at the time of purchase, but the Company also purchased
several that were rated investment grade which, because of market pricing, offer
yields commensurate with below-investment-grade risk profiles. The objective of
this allocation was to enhance the Company's yield on invested assets and
further diversify credit risk. All investments in this program must have a
minimum rating at purchase of low BB using the Company's above described rating
methodology and are managed by the Company's internal credit portfolio
management team.

Fixed Maturity Securities by Sector

The Company maintains diversification in investments by sector to avoid
concentrations to any one sector, thus managing exposure risk. The following
table shows the distribution of fixed maturities by sector classification.

                                                                                                   March 31, 2023
                                                                                                         Gross
                                                                             Gross Unrealized         Unrealized                                      % of
(In millions)                                   Amortized Cost (1)                Gains                 Losses              Fair Value                Total
Government and agencies                     $                43,595          $       4,082          $     (1,084)         $    46,593                      46.3  %
Municipalities                                                2,593                    261                   (97)               2,757                       2.8
Mortgage- and asset-backed securities                         2,545                     99                   (77)               2,567                       2.7
Public utilities                                              7,495                    671                  (191)               7,975                       7.9
Electric                                                      6,074                    551                  (134)               6,489                       6.4
Natural Gas                                                     844                     69                   (32)                 882                        .9
Other                                                           577                     51                   (25)                 604                        .6
Sovereign and supranational                                   1,118                    134                   (14)               1,238                       1.2
Banks/financial institutions                                  9,279                    653                  (512)               9,420                       9.8
Banking                                                       5,571                    455                  (295)               5,732                       5.9
Insurance                                                     1,716                    143                   (67)               1,791                       1.8
Other                                                         1,992                     55                  (150)               1,897                       2.1
Other corporate                                              27,617                  2,655                (1,107)              29,165                      29.3
Basic Industry                                                2,444                    307                   (83)               2,669                       2.6
Capital Goods                                                 3,275                    231                  (147)               3,359                       3.5
Communications                                                2,906                    375                   (66)               3,214                       3.1
Consumer Cyclical                                             2,136                    219                   (50)               2,305                       2.3
Consumer Non-Cyclical                                         6,148                    522                  (240)               6,429                       6.5
Energy                                                        2,556                    359                   (60)               2,855                       2.7
Other                                                         1,343                     95                  (113)               1,325                       1.4
Technology                                                    3,701                    185                  (171)               3,716                       3.9
Transportation                                                3,108                    362                  (177)               3,293                       3.3
    Total fixed maturity securities         $                94,242          $       8,555          $     (3,082)         $    99,715                   

100.0 %

(1) Net of allowance for credit losses

Securities by Type of Issuance


The Company has investments in both publicly and privately issued securities.
The Company's ability to sell either type of security is a function of overall
market liquidity which is impacted by, among other things, the amount of
outstanding securities of a particular issuer or issuance, trading history of
the issue or issuer, overall market conditions, and idiosyncratic events
affecting the specific issue or issuer.

                                       95
--------------------------------------------------------------------------------

The following table details investment securities by type of issuance.

                   Investment Securities by Type of Issuance

                                               March 31, 2023                          December 31, 2022
                                       Amortized             Fair                Amortized             Fair
(In millions)                          Cost (1)              Value               Cost (1)              Value
Publicly issued securities:
Fixed maturity securities              $ 76,825            $  81,310            $  77,176            $ 79,090
Equity securities                           866                  866                  882                 882
   Total publicly issued                 77,691               82,176               78,058              79,972
Privately issued securities: (2)
Fixed maturity securities (3)            17,417               18,405               17,349              17,861
Equity securities                           221                  221                  209                 209
   Total privately issued                17,638               18,626               17,558              18,070
   Total investment securities         $ 95,329            $ 100,802            $  95,616            $ 98,042

(1) Net of allowance for credit losses
(2) Primarily consists of securities owned by Aflac Japan (3) Excludes Rule 144A securities

The following table details the Company's reverse-dual currency securities.

                      Reverse-Dual Currency Securities(1)

                                                                 March 31,                      December 31,
(Amortized cost, in millions)                                       2023                            2022
Privately issued reverse-dual currency securities                $ 4,028                           $ 4,049

Publicly issued collateral structured as reverse-dual
currency securities

                                                1,374                             1,383
Total reverse-dual currency securities                           $ 5,402                           $ 5,432
Reverse-dual currency securities as a percentage of total
investment
  securities                                                         5.7  %                            5.7  %

(1) Principal payments in yen and interest payments in dollars


Aflac Japan has a portfolio of privately issued securities to better match
liability characteristics and secure higher yields than those available on
Japanese government or other public corporate bonds. Aflac Japan's investments
in yen-denominated privately issued securities consist primarily of non-Japanese
issuers, are rated investment grade at purchase and have longer maturities,
thereby allowing the Company to improve asset/liability matching and overall
investment returns. These securities are generally either privately negotiated
arrangements or issued under medium-term note programs and have standard
documentation commensurate with credit ratings of the issuer, except when
internal credit analysis indicates that additional protective and/or event-risk
covenants were required. Many of these investments have protective covenants
appropriate to the specific investment. These may include a prohibition of
certain activities by the borrower, maintenance of certain financial measures,
and specific conditions impacting the payment of the Company's notes.

                               HEDGING ACTIVITIES

The Company uses derivative contracts to hedge foreign currency exchange rate
risk and interest rate risk. The Company uses various strategies, including
derivatives, to manage these risks. See Item 7A. Quantitative and Qualitative
Disclosures About Market Risk in the 2022 Annual Report for more information
about market risk and the Company's use of derivatives.

Derivatives are designed to reduce risk on an economic basis while minimizing
the impact on financial results. The Company's derivatives programs vary
depending on the type of risk being hedged. See Note 4 of the Notes to the
Consolidated Financial Statements for:


•A description of the Company's derivatives, hedging strategies and underlying
risk exposure.
•Information about the notional amount and fair market value of the Company's
derivatives.
                                       96
--------------------------------------------------------------------------------

•The unrealized and realized gains and losses impact on adjusted earnings of
derivatives in cash flow, fair value, net investments in foreign operations, or
non-qualifying hedging relationships.

Foreign Currency Exchange Rate Risk Hedge Program

The Company has deployed the following hedging strategies to mitigate exposure
to foreign currency exchange rate risk:

•Aflac Japan hedges U.S. dollar-denominated investments back to yen (see Aflac
Japan's
U.S. Dollar-Denominated Hedge Program below).

•Aflac Japan maintains certain unhedged U.S. dollar-denominated securities,
which serve as an economic currency hedge of a portion of the Company's
investment in Aflac Japan (see Aflac Japan's U.S. Dollar-Denominated Hedge
Program below).

•The Parent Company designates yen-denominated liabilities (notes payable and
loans) as non-derivative hedging instruments and designates certain foreign
currency forwards and options as derivative hedges of the Company's net
investment in Aflac Japan (see Enterprise Corporate Hedging Program below).


•The Parent Company enters into forward and option contracts to accomplish a
dual objective of hedging foreign currency exchange rate risk related to
dividend payments by its subsidiary, ALIJ, and reducing enterprise-wide hedge
costs (see Enterprise Corporate Hedging Program below).


The following table presents metrics related to Aflac Japan's U.S.
dollar-denominated hedge program and the Parent Company's enterprise corporate
hedging program, including associated amortized hedge costs/income, for the
periods ended March 31. See the Results of Operations section of this MD&A for
the Company's definition of amortized hedge costs/income.

                                                                                   Three Months
                                                                                                2023             2022
Aflac Japan:
FX Forwards

FX forward (sell USD, buy yen) notional at end of period (in
billions) (1)

                    $3.7             $4.5
  Weighted average remaining tenor (in months) (2)                                              9.8              9.9
  Amortized hedge income (cost) for period (in millions)                                       $(39)            $(13)
FX Options
FX option notional at the end of period (in billions) (1)                                      $13.5            $13.5
Weighted average remaining tenor (in months) (2)                                                7.4              6.6
Amortized hedge income (cost) for period (in millions)                                         $(19)            $(13)
Corporate and other (Parent Company):
FX Forwards

FX forward (buy USD, sell yen) notional at end of period (in
billions) (1)

                    $5.0             $5.0
  Weighted average remaining tenor (in months) (2)                                              10.4             10.9
  Amortized hedge income (cost) for period (in millions)                                        $31              $12
FX Options
FX option notional at the end of period (in billions) (1)                                       $2.2             $1.9
Weighted average remaining tenor (in months) (2)                                                7.4              7.6
Amortized hedge income (cost) for period (in millions)                                          $(2)             $(1)


(1) Notional is reported net of any offsetting positions within Aflac Japan or
the Parent Company, respectively.
(2) Tenor based on period reporting date to settlement date

Amortized hedge costs/income can fluctuate based upon many factors, including
the derivative notional amount, the length of time of the derivative contract,
changes in both U.S. and Japan interest rates, and supply and demand for dollar
funding. Amortized hedge costs/income have fluctuated in recent periods due to
changes in the previously mentioned factors.

                                       97
--------------------------------------------------------------------------------

Aflac Japan's U.S. Dollar-Denominated Hedge Program (U.S. Dollar Program)


Aflac Japan buys U.S. dollar-denominated investments, typically corporate bonds,
and hedges them back to yen with foreign currency forwards and options to hedge
foreign currency exchange rate risk. This economically creates yen assets that
match yen liabilities during the life of the derivative and provides favorable
capital treatment under the Japan solvency margin ratio (SMR) calculations. The
currency risk being hedged is generally based on fair value of hedged
investments. The following table summarizes the U.S. dollar-denominated
investments held by Aflac Japan.

                                                               March 31,                           December 31,
                                                                  2023                                 2022
                                                      Amortized            Fair            Amortized            Fair
(In millions)                                          Cost (1)            Value            Cost (1)            Value

Available-for-sale securities:

 Fixed maturity securities                           $  12,817          $ 14,176          $  14,321          $ 15,191

Equity securities                                           33                33                 33                33

Commercial mortgage and other loans:

 Transitional real estate loans (floating rate)          5,277             5,207              5,133             5,088
 Commercial mortgage and other loans                     1,134             1,013              1,269             1,129
 Middle market loans (floating rate)                     4,474             4,468              4,557             4,545
Other investments                                        2,033             2,033              1,899             1,899
   Total U.S. Dollar Program                            25,768            26,930             27,212            27,885

Available-for-sale securities:

Fixed maturity securities - economically converted
to yen

                                                   2,236             2,928              2,209             2,795
   Total U.S. dollar-denominated investments in
Aflac Japan                                          $  28,004          $ 

29,858 $ 29,421 $ 30,680

(1) Net of allowance for credit losses


The U.S. Dollar Program includes all U.S. dollar-denominated investments in
Aflac Japan other than the investments in certain consolidated VIEs where the
instrument is economically converted to yen as a result of a derivative in the
consolidated VIE. The Company uses one-sided foreign currency put options to
mitigate the settlement risk on U.S. dollar-denominated assets related to
extreme foreign currency rate changes. From time to time, Aflac Japan also
maintains a collar program on a portion of its U.S. Dollar Program to mitigate
against more extreme moves in foreign exchange and therefore support SMR. As of
March 31, 2023, there were no collars in Aflac Japan, and none of the Company's
foreign currency options hedging Aflac Japan's U.S. dollar-denominated assets
were in-the-money.

As of March 31, 2023, the fair value of Aflac Japan's unhedged U.S.
dollar-denominated portfolio was $9.7 billion (excluding certain U.S.
dollar-denominated assets shown in the table above as a result of consolidation
that have been economically converted to yen using derivatives).


Foreign exchange derivatives used for hedging are periodically settled, which
results in cash receipt or payment at maturity or early termination. The
following table presents the settlements associated with the Company's currency
derivatives used for hedging Aflac Japan's U.S. dollar-denominated investments.

                                         Three Months Ended March 31,
(In millions)                                                2023                   2022
Net cash inflows (outflows)                                                       $ (579)           $ (619)



Enterprise Corporate Hedging Program


The Company has designated certain yen-denominated liabilities and foreign
currency forwards and options of the Parent Company as accounting hedges of its
net investment in Aflac Japan. The Company's consolidated yen-denominated net
asset position was partially hedged at $11.1 billion as of March 31, 2023, with
hedging instruments comprised of $3.9 billion of yen-denominated debt and $7.2
billion of foreign currency forwards and options, compared with $11.6 billion as
of December 31, 2022, with hedging instruments comprised of $4.0 billion of
yen-denominated debt and $7.6 billion of foreign currency forwards and options.

                                       98
--------------------------------------------------------------------------------

The Company makes its accounting designation of net investment hedge at the
beginning of each quarter. If the total of the designated Parent Company
non-derivative and derivative notional is equal to or less than the Company's
net investment in Aflac Japan, the hedge is deemed to be effective, and the
currency exchange effect on the yen-denominated liabilities and the change in
estimated fair value of the derivatives are reported in the unrealized foreign
currency component of other comprehensive income. The Company's net investment
hedge was effective during the three-month periods ended March 31, 2023 and
2022, respectively. For additional information on the Company's net investment
hedging strategy, see Note 4 of the Notes to the Consolidated Financial
Statements.

In order to economically mitigate risks associated with the enterprise-wide
exposure to the yen and the level and volatility of hedge costs, the Parent
Company enters into foreign exchange forward and option contracts. By buying
U.S. dollars and selling yen, the Parent Company is effectively lowering its
overall economic exposure to the yen, while Aflac Japan's U.S. dollar exposure
remains reduced as a result of Aflac Japan's U.S. Dollar Program that
economically creates yen assets. Among other objectives, this strategy is
intended to offset the enterprise-wide amortized hedge costs by generating
amortized hedge income. This activity is reported in Corporate and other. The
Company continually evaluates the program's efficacy.

As part of the Company's internal reinsurance platform, Aflac Re enters into
foreign currency forwards with the Parent Company to economically manage the
currency mismatch between Aflac Re's assets, which are mostly denominated in
U.S. dollars, and liabilities, which are mostly denominated in yen, in order to
support and optimize BMA capital requirements. For additional information on the
Company's internal reinsurance platform, see Note 8 of the Notes to the
Consolidated Financial Statements and the Liquidity and Capital Resources
section of this MD&A.

Interest Rate Risk Hedge Program


Aflac Japan and Aflac U.S. use interest rate swaps from time to time to mitigate
the risk of investment income volatility for certain variable-rate investments.
Additionally, to manage interest rate risk associated with its U.S.
dollar-denominated investments held by Aflac Japan, from time to time the
Company utilizes interest rate swaptions.

For additional discussion of the risks associated with the foreign currency
exposure refer to the Currency Risk section in Item 7A., Quantitative and
Qualitative Disclosures about Market Risk, and Item 1A, specifically to the Risk
Factors titled "The Company is exposed to foreign currency fluctuations in the
yen/dollar exchange rate" and "Lack of availability of acceptable
yen-denominated investments could adversely affect the Company's results of
operations, financial position or liquidity" in the 2022 Annual Report.

See Note 4 of the Notes to the Consolidated Financial Statements for additional
information on the Company's hedging activities.

                       DEFERRED POLICY ACQUISITION COSTS

The following table presents deferred policy acquisition costs by segment.

                      March 31,
(In millions)           2023               December 31, 2022               % Change
Aflac Japan            $ 5,776                      $ 5,776                        .0  % (1)
Aflac U.S.               3,491                        3,463                        .8

Total                  $ 9,267                      $ 9,239                        .3  %


(1) Aflac Japan's deferred policy acquisition costs increased .6% in yen during
the three months ended March 31, 2023.
Prior-year amounts have been adjusted for the adoption of accounting guidance on
January 1, 2023 related to accounting for long-duration insurance contracts.


See Note 6 of the Notes to the Consolidated Financial Statements for additional
information on the Company's deferred policy acquisition costs.

                                       99
--------------------------------------------------------------------------------

                               POLICY LIABILITIES

The following table presents policy liabilities by segment.

                                     March 31,
(In millions)                          2023               December 31, 2022                % Change
Aflac Japan                          $ 88,944                     $ 86,088                         3.3  % (1)
Aflac U.S.                             11,542                       11,187                         3.2
Corporate and other                     1,874                          302                       100.0
Intercompany eliminations(2)           (2,427)                        (667)                      100.0
Total                                $ 99,933                     $ 96,910                         3.1  %


(1) Aflac Japan's policy liabilities increased 4.0% in yen during the three
months ended March 31, 2023.
(2) Elimination entry necessary due to the internal reinsurance transaction with
Aflac Re and to recapture of a portion of policy liabilities ceded externally as
a result of the reinsurance retrocession transaction. See Note 8 of the Notes to
the Consolidated Financial Statements.
Prior-year amounts have been adjusted for the adoption of accounting guidance on
January 1, 2023 related to accounting for long-duration insurance contracts.

See Note 7 of the Notes to the Consolidated Financial Statements for additional
information on the Company's policy liabilities.

                                 BENEFIT PLANS

Aflac Japan and Aflac U.S. have various benefit plans. For additional
information on the Company's Japanese and U.S. plans, see Note 12 of the
accompanying Notes to the Consolidated Financial Statements and Note 14 of the
Notes to the Consolidated Financial Statements in the 2022 Annual Report.

                            POLICYHOLDER PROTECTION

Policyholder Protection Corporation


The Japanese insurance industry has a policyholder protection system that
provides funds for the policyholders of insolvent insurers. Legislation enacted
regarding the framework of the Life Insurance Policyholder Protection
Corporation (LIPPC) included government fiscal measures supporting the LIPPC. In
March 2022, Japan's Diet passed legislation that extended the government's
fiscal support of the LIPPC through March 2027. In March 2022, the LIPPC reached
the required balance for the total life industry of ¥400 billion as specified by
its Articles of Incorporation. As a result, additional contributions are not
expected to be required unless the balance is reduced due to payments made by
the LIPPC to the policyholders of insolvent insurers. Accordingly, Aflac Japan
did not recognize an expense for LIPPC assessments for the three-month period
ended March 31, 2023. Aflac Japan recognized an expense for LIPPC assessments of
¥.9 billion for the three-month period ended March 31, 2022.

Guaranty Fund Assessments


Under U.S. state guaranty association laws, certain insurance companies can be
assessed (up to prescribed limits) for certain obligations to the policyholders
and claimants of impaired or insolvent insurance companies that write the same
line or similar lines of business. The amount of the guaranty fund assessment
that an insurer is assessed is based on its proportionate share of premiums in
that state. Guaranty fund assessments for the three-month periods ended
March 31, 2023 and 2022 were immaterial.

                        LIQUIDITY AND CAPITAL RESOURCES

Liquidity refers to the ability to generate sufficient cash resources to meet
the payment obligations of the Company. Capital refers to the long-term
financial resources available to support the operations of the businesses, fund
business growth and provide for an ability to withstand adverse circumstances.
Financial leverage (leverage) refers to an investment strategy of using debt to
increase the potential ROE. The Company targets and actively manages liquidity,
capital and leverage in the context of a number of considerations, including:

•business investment and growth needs
•strategic growth objectives
•financial flexibility and obligations
                                      100
--------------------------------------------------------------------------------

•capital support for hedging activity
•a constantly evolving business and economic environment
•a balanced approach to capital allocation and shareholder deployment.

The governance framework supporting liquidity, capital and leverage includes
global senior management and board committees that review and approve all
significant capital related decisions.


The Company's cash and cash equivalents include unrestricted cash on hand, money
market instruments, and other debt instruments with a maturity of 90 days or
less when purchased, all of which have minimal market, settlement or other risk
exposure. The target minimum amount for the Parent Company's cash and cash
equivalents is approximately $1.8 billion to provide a capital buffer and
liquidity support at the holding company. The Company remains committed to
prudent liquidity and capital management. At March 31, 2023, the Company held
$3.8 billion in cash and cash equivalents for stress conditions, which includes
the Parent Company's target minimum amount of $1.8 billion.

Aflac Japan and Aflac U.S. generate cash flows from their operations and provide
the primary sources of liquidity to the Parent Company through management fees
and dividends, with Aflac Japan being the largest contributor. The primary uses
of cash by the Parent Company are shareholder dividends, the repurchase of its
common stock, interest on its outstanding indebtedness and operating expenses.

The following table presents the amounts provided to the Parent Company for the
three-month periods ended March 31.

              Liquidity Provided by Subsidiaries to Parent Company

(In millions)                                 2023      2022

Management fees paid by subsidiaries $ 38 $ 33
Dividends declared or paid by subsidiaries 780 514

The following table details Aflac Japan remittances, which are included in the
totals above, for the three-month periods ended March 31.

                            Aflac Japan Remittances

(In millions of dollars and billions of yen)                  2023          

2022

Aflac Japan management fees paid to Parent Company $ 16

$ 15

Aflac Japan dividends declared or paid to Parent Company
(in dollars)

                                                   505                     339
Aflac Japan dividends declared or paid to Parent Company
(in yen)                                                    ¥ 67.3                  ¥ 41.1



The Company intends to maintain higher than historical levels of liquidity and
capital at the Parent Company for stress conditions and with the goals of
addressing the Company's hedge costs and related potential need for collateral
and mitigating against long-term weakening of the Japanese yen. Further, the
Company plans to continue to maintain a portfolio of unhedged U.S.
dollar-denominated investments at Aflac Japan and to consider whether the amount
of such investments should be increased or decreased relative to the Company's
view of economic equity surplus in Aflac Japan in light of potentially rising
hedge costs and other factors. See the Hedging Activity subsection of this MD&A
for more information.

The Company believes that its balance of cash and cash equivalents and cash
generated by operations will be sufficient to satisfy both its short-term and
long-term cash requirements and plans for cash, including material cash
requirements from known contractual obligations and returning capital to
shareholders through share repurchases and dividends. For additional
information, see the Liquidity and Capital Resources section of Item 7. MD&A in
the 2022 Annual Report.

In addition to cash and cash equivalents, the Company also maintains credit
facilities, both intercompany and with external partners, and a number of other
available tools to support liquidity needs on a global basis. In September 2021,
the Parent Company filed a shelf registration statement with the SEC that allows
the Company to issue an indefinite amount of debt securities, in one or more
series, from time to time until September 2024. The Company believes outside
sources for additional debt and equity capital, if needed, will continue to be
available. Additionally, as of March 31, 2023, the Parent Company and Aflac had
four lines of credit with third parties and twelve intercompany lines of credit.
The Company was in compliance with all of the covenants of its notes payable and
lines of credit at March 31, 2023. For additional information, see Note 9 of the
Notes to the Consolidated Financial Statements.

                                      101
--------------------------------------------------------------------------------

As part of enterprise-wide capital management and optimization, the Company also
utilizes the newly-created intercompany reinsurance platform to execute internal
reinsurance transactions with Aflac Re. For additional information, see Note 8
of the Notes to the Consolidated Financial Statements.

The Company's consolidated financial statements convey its financing
arrangements during the periods presented. The Company has not engaged in
material intra-period short-term financings during the periods presented that
are not otherwise reported in its balance sheet or disclosed therein. As of
March 31, 2023, the Company had no material letters of credit, standby letters
of credit, guarantees or standby repurchase obligations. The Company has not
entered into transactions involving the transfer of financial assets with an
obligation to repurchase financial assets that have been accounted for as a sale
under applicable accounting standards, including securities lending
transactions. See Notes 3 and 4 of the Notes to the Consolidated Financial
Statements and Notes 1, 3, and 4 of the Notes to the Consolidated Financial
Statements in the 2022 Annual Report for more information on the Company's
securities lending and derivative activities. See Note 15 of the Notes to the
Consolidated Financial Statements in the 2022 Annual Report for information on
material unconditional purchase obligations that are not recorded on the
Company's balance sheet. With the exception of disclosed activities in those
referenced footnotes and the Risk Factors in the 2022 Annual Report entitled,
"The Company is exposed to foreign currency fluctuations in the yen/dollar
exchange rate" and "Lack of availability of acceptable yen-denominated
investments could adversely affect the Company's results of operations,
financial position or liquidity," the Company is not aware of any trend, demand,
commitment, event or uncertainty that would reasonably result in its liquidity
increasing or decreasing by a material amount.

                            Consolidated Cash Flows

The Company consistently generates positive cash flows from operations, and has
the ability to adjust cash flow management from other sources of liquidity
including reinvestment cash flows and selling investments in order to meet
short-term cash needs.


The Company translates cash flows for Aflac Japan's yen-denominated items into
U.S. dollars using weighted-average exchange rates. In periods when the yen
weakens, translating yen into dollars causes fewer dollars to be reported. When
the yen strengthens, translating yen into dollars causes more dollars to be
reported.

The following table summarizes consolidated cash flows by activity for the
three-month periods ended March 31.


(In millions)                                     2023        2022
Operating activities                            $  708      $ 1,260
Investing activities                               105       (1,210)
Financing activities                              (933)        (737)

Exchange effect on cash and cash equivalents (14) (89)
Net change in cash and cash equivalents $ (134) $ (776)

                              Operating Activities

The principal cash inflows for the Company's insurance activities come from
insurance premiums and investment income. The principal cash outflows are the
result of policy claims, operating expenses, income tax, as well as interest
expense. As a result of policyholder aging, claims payments are expected to
gradually increase over the life of a policy. Therefore, future policy benefit
reserves are accumulated in the early years of a policy and are designed to help
fund future claims payments.

The Company expects its future cash flows from premiums and investment
portfolios to be sufficient to meet its cash needs for benefits and expenses.

                              Investing Activities

The Company's investment objectives provide for liquidity primarily through the
purchase of publicly traded investment-grade debt securities. Prudent portfolio
management dictates that the Company attempts to match the duration of its
assets with the duration of its liabilities. Currently, when the Company's fixed
maturity securities mature, the proceeds may be reinvested at a yield below that
required for the accretion of policy benefit liabilities on policies issued in
earlier years. However, the long-term nature of the Company's business and its
strong cash flows provide the Company with the ability to minimize the effect of
mismatched durations and/or yields identified by various asset adequacy
analyses. From time to time or when market opportunities arise, the Company
disposes of selected fixed maturity securities that are available for
                                      102
--------------------------------------------------------------------------------

sale to improve the duration matching of assets and liabilities, improve future
investment yields, and/or re-balance its portfolio. As a result, dispositions
before maturity can vary significantly from year to year.

As part of its overall corporate strategy, the Company has committed $400
million to Aflac Ventures, LLC (Aflac Ventures), as opportunities emerge. Aflac
Ventures is a subsidiary of Aflac Global Ventures, LLC (Aflac Global Ventures)
which is reported in Corporate and other. The central mission of Aflac Global
Ventures is to support the organic growth and business development needs of
Aflac Japan and Aflac U.S. with an emphasis on digital applications designed to
improve the customer experience, gain efficiencies, and develop new markets in
an effort to enhance and defend long-term shareholder value. Investments are
included in equity securities or the other investments line in the consolidated
balance sheets.

As part of an arrangement with Federal Home Loan Bank of Atlanta (FHLB), Aflac
U.S. obtains low-cost funding from FHLB supported by acceptable forms of
collateral pledged by Aflac U.S. In the first three months of 2023, Aflac U.S.
borrowed and repaid $37 million under this program. As of March 31, 2023, Aflac
U.S. had outstanding borrowings of $591 million reported in its balance sheet.

See Note 3 of the Notes to the Consolidated Financial Statements for details on
certain investment commitments.

                              Financing Activities

Cash flows from financing activities consist primarily of share repurchases,
dividends to shareholders and from time to time debt issuances and redemptions.


Cash returned to shareholders through treasury stock purchases and dividends was
$948 million during the three-month period ended March 31, 2023, compared with
$750 million during the three-month period ended March 31, 2022.

The following tables present a summary of treasury stock activity during the
three-month periods ended March 31.

                            Treasury Stock Purchased

(In millions of dollars and thousands of shares)      2023         2022
Treasury stock purchases                           $    700      $  500
Number of shares purchased:
Share repurchase program                             10,348       8,007
Other                                                   347         343
  Total shares purchased                             10,695       8,350



                             Treasury Stock Issued

(In millions of dollars and thousands of shares) 2023 2022
Stock issued from treasury:

  Cash financing                                   $  2      $  9
  Noncash financing                                  18        17
  Total stock issued from treasury                 $ 20      $ 26
Number of shares issued                             458       526



As of March 31, 2023, a remaining balance of 106.3 million shares of the
Company's common stock was available for purchase under share repurchase
authorizations by its board of directors.


Cash dividends paid to shareholders were $.42 per share in the first quarter of
2023, compared with $.40 per share in the first quarter of 2022. The following
table presents the dividend activity for the three-month periods ended March 31.

(In millions)                                    2023       2022
Dividends paid in cash                          $ 248      $ 250

Dividends through issuance of treasury shares 9 9
Total dividends to shareholders

                 $ 257      $ 259


                                      103
--------------------------------------------------------------------------------


In April 2023, the board of directors declared the second quarter cash dividend
of $.42 per share, an increase of 5.0% compared with the same period in 2022.
The dividend is payable on June 1, 2023 to shareholders of record at the close
of business on May 17, 2023.

                            Regulatory Restrictions

Aflac Japan


Aflac Japan is required to meet certain financial criteria as governed by
Japanese corporate law in order to provide dividends to the Parent Company.
Under these criteria, dividend capacity at the Japan subsidiary is basically
defined as total equity excluding common stock and capital reserves
(representing statutorily required amounts in Japan) but reduced for net
after-tax unrealized losses on available-for-sale securities. These dividend
capacity requirements are generally aligned with the SMR. Japan's Financial
Services Agency (FSA) maintains its own solvency standard which is quantified
through the SMR. Aflac Japan's SMR is sensitive to interest rate, credit spread,
and foreign exchange rate changes; therefore, the Company continues to evaluate
alternatives for reducing this sensitivity, including the reduction of
subsidiary dividends paid to the Parent Company and Parent Company capital
contributions. In the event of a rapid change in market risk conditions causing
SMR to decline, the Company has one senior unsecured revolving credit facility
in the amount of ¥100 billion and a committed reinsurance facility in the amount
of approximately ¥120 billion as a capital contingency plan. Additionally,
subject to market conditions, the Company expects that it could take action to
enter into derivatives on unhedged U.S. dollar-denominated investments with
foreign currency options or forwards or execute additional internal reinsurance
transactions with Aflac Re. See Notes 8 and 9 of the Notes to the Consolidated
Financial Statements for additional information.

The Company has already undertaken various measures to mitigate the sensitivity
of Aflac Japan's SMR. For example, the Company employs policy reserve matching
(PRM) investment strategies, which is a Japan-specific accounting treatment that
reduces SMR interest rate sensitivity since PRM-designated investments are
carried at amortized cost consistent with corresponding liabilities. In order
for a PRM-designated asset to be held at amortized cost, there are certain
criteria that must be maintained. The primary criterion relates to maintaining
the duration of designated assets and liabilities within a specified tolerance
range. If the duration difference is not maintained within the specified range
without rebalancing, then a certain portion of the assets must be re-classified
as available for sale and held at fair value with any associated unrealized gain
or loss recorded in surplus. To rebalance, assets may need to be sold in order
to maintain the duration with the specified range, resulting in realizing a gain
or loss from the sale. For U.S. GAAP, PRM investments are categorized as
available for sale. The Company also uses foreign currency derivatives to hedge
a portion of its U.S. dollar-denominated investments. See Notes 3, 4 and 8 of
the Notes to the Consolidated Financial Statements in the 2022 Annual Report for
additional information on the Company's investment strategies, hedging
activities, and reinsurance, respectively.

As of March 31, 2023, Aflac Japan's SMR remains high and reflects a strong
capital and surplus position. The Company is committed to maintaining strong
capital levels, consistent with maintaining current insurance financial strength
and credit ratings.

The FSA is considering the introduction of an economic value-based solvency
regime based on the Insurance Capital Standards (ICS) for insurance companies in
Japan. The FSA continues to conduct field testing with insurance companies in
Japan for the purpose of investigating the impact of the introduction of such
regulations. Final specifications are expected to be decided in 2024, and a new
capital regime to replace the current solvency regime is expected to be
introduced in 2025.

Aflac U.S.


A life insurance company's statutory capital and surplus is determined according
to rules prescribed by the National Association of Insurance Commissioners
(NAIC), as modified by the insurance department in the insurance company's state
of domicile. Statutory accounting rules are different from U.S. GAAP and are
intended to emphasize policyholder protection and company solvency. The
continued long-term growth of the Company's business may require increases in
the statutory capital and surplus of its insurance operations. The Company's
insurance operations may secure additional statutory capital through various
sources, such as internally generated statutory earnings, reduced dividends paid
to the Parent Company, capital contributions by the Parent Company from funds
generated through debt or equity offerings, or reinsurance transactions. The
NAIC's Risk-based capital (RBC) formula is used by insurance regulators to help
identify inadequately capitalized insurance companies. The RBC formula
quantifies insurance risk, business risk, asset risk and
                                      104
--------------------------------------------------------------------------------

interest rate risk by weighing the types and mixtures of risks inherent in the
insurer's operations. As of March 31, 2023, Aflac U.S.'s combined RBC ratio
remains high and reflects a strong capital and surplus position.


Aflac, CAIC and TOIC are domiciled in Nebraska and are subject to its
regulations. The maximum amount of dividends that can be paid to the Parent
Company by Aflac, CAIC and TOIC without prior approval of Nebraska's director of
insurance is the greater of the net income from operations, which excludes net
investment gains, for the previous year determined under statutory accounting
principles, or 10% of statutory capital and surplus as of the previous year-end.
Dividends declared by Aflac during 2023 in excess of $1.1 billion would be
considered extraordinary and require such approval. Similar laws apply in New
York, the domiciliary jurisdiction of Aflac New York.

                      Privacy and Cybersecurity Governance

The Company's Board of Directors has adopted an information security policy
directing management to establish and operate a global information security
program with the goals of monitoring existing and emerging threats and ensuring
that the Company's information assets and data, and the data of its customers,
are appropriately protected from loss or theft. The Board has delegated
oversight of the Company's information security program to the Audit and Risk
Committee. The Company's senior officers, including its Global Chief Information
Security Officer, are responsible for the operation of the global information
security program and communicate quarterly with the Audit and Risk Committee on
the program, including with respect to the state of the program, compliance with
applicable regulations, current and evolving threats, and recommendations for
changes in the information security program. The global information security
program also includes a cybersecurity incident response plan that is designed to
provide a management framework across Company functions for a coordinated
assessment and response to potential security incidents. This framework
establishes a protocol to report certain incidents to the Global Chief
Information Security Officer and other senior officers, with the goal of timely
assessing such incidents, determining applicable disclosure requirements and
communicating with the Audit and Risk Committee. The incident response plan
directs the executive officers to report certain incidents immediately and
directly to the Lead Non-Management Director.

                                     Other

For information regarding commitments and contingent liabilities, see Note 13 of
the Notes to the Consolidated Financial Statements.

                             Additional Information

Investors should note that the Company announces material financial information
in its SEC filings, press releases and public conference calls. In accordance
with SEC guidance, the Company may also use the Investor Relations section of
the Company's website (http://investors.aflac.com) to communicate with investors
about the Company. It is possible that the financial and other information the
Company posts there could be deemed to be material information. The information
on the Company's website is not part of this document. Further, the Company's
references to website URLs are intended to be inactive textual references only.

                         CRITICAL ACCOUNTING ESTIMATES

The Company prepares its financial statements in accordance with U.S. GAAP.
These principles are established primarily by the Financial Accounting Standards
Board (FASB). In this MD&A, references to U.S. GAAP issued by the FASB are
derived from the FASB Accounting Standards Codification™ (ASC). The preparation
of financial statements in conformity with U.S. GAAP requires the Company to
make estimates based on currently available information when recording
transactions resulting from business operations. The estimates that the Company
deems to be most critical to an understanding of its results of operations and
financial condition are those related to the valuation of investments and
derivatives, DAC, liabilities for future policy benefits, and income taxes. The
preparation and evaluation of these critical accounting estimates involve the
use of various assumptions developed from management's analyses and judgments.
Calculations of DAC and the liability for future policy benefits require the use
of estimates based on actuarial valuation techniques. The application of these
critical accounting estimates determines the values at which 93% of the
Company's assets and 80% of its liabilities are reported as of March 31, 2023,
and thus has a direct effect on net earnings and shareholders' equity.
Subsequent experience or use of other assumptions could produce significantly
different results.

On January 1, 2023, the Company adopted Accounting Standards Update (ASU)
2018-12, Financial Services - Insurance: Targeted Improvements to the Accounting
for Long-Duration Contracts (LDTI). The update significantly changes how
insurers account for long-duration contracts and amends existing recognition,
measurement, presentation, and disclosure requirements applicable to the Company
related to liabilities for future policy benefits and DAC. As part of this
adoption,
                                      105
--------------------------------------------------------------------------------

the Company measures together all payments under an insurance contract including
future expected claims and unpaid policy claims and related expenses, as an
integrated reserve. This resulted in unpaid policy claims on long-duration
insurance contracts and accrued claim adjustment expenses that were presented
separately in the Company's consolidated balance sheet pre-adoption to now be
presented as part of liabilities for future policy benefits.

For additional information, see Note 1 of the Notes to the Consolidated
Financial Statements in this document and in the 2022 Annual Report.

Deferred Policy Acquisition Costs


Amortization of DAC is computed using the same contract groupings (also referred
to as cohorts) and mortality and termination assumptions that are used in
computing the liability for future policy benefits, and these assumptions are
reviewed and updated at least annually. The effects of changes in assumptions
are recognized prospectively over the remaining contract term as a revision of
future amortization pattern, while current period amortization is calculated
based on the actual experience during the quarter. For additional information,
see Note 6 of the Notes to the Consolidated Financial Statements.

Future Policy Benefits


The Company's liabilities for future policy benefits are determined in
accordance with applicable guidelines as defined under U.S. GAAP and Actuarial
Standards of Practice and represent claims that are expected to occur in the
future and already incurred claims (which represent claims that have been
incurred and are in the process of payment as well as an estimate of those
claims that have been incurred but have not yet been reported to the Company)
and are measured using the net level premium method. Future policy benefits are
calculated using assumptions and estimates including mortality, morbidity,
termination (also referred to as lapses), expense, and discount rates. The
assumptions and estimates that the Company uses depend on its judgment regarding
the likelihood of future events and are inherently uncertain.

Cash flow assumptions (mortality, morbidity, and termination) are established at
policy inception and are evaluated each quarter to determine if an update is
needed. To facilitate a more detailed review of cash flow assumptions,
experience studies are performed annually during the third quarter. Changes in
cash flow assumptions are recognized in reserve remeasurement (gains) losses in
the consolidated statement of earnings. Expense assumptions are established at
policy inception and are not updated. Actual experience is reflected in the
calculation of future policy benefits each quarter, and changes in the liability
due to actual experience are recognized in reserve remeasurement (gains) losses
in the consolidated statement of earnings.

Discount rates used to calculate net premiums are locked in at policy inception
and represent the basis to recognize interest expense in the consolidated
statement of earnings. Discount rates used to measure the carrying value of
liability for future policy benefits in the consolidated balance sheet are
updated each reporting period, and the differences between the liability
balances calculated using the locked-in discount rates and the updated discount
rates are recognized in other comprehensive income (loss) (OCI). The discount
rate methodology is designed to prioritize observable inputs based on market
data available in the local debt markets where the respective policies were
issued in the currency in which the policies are denominated. For the discount
rates applicable to tenors for which the single-A debt market is not liquid or
there is little or no observable market data, the Company uses various
estimation techniques consistent with the fair value guidance in ASC 820, which
include, but are not limited to: (i) for tenors where there is less observable
market data and/or the observable market data is available for similar
instruments, estimating tenor-specific single-A credit spreads and applying them
to risk-free government rates? (ii) for tenors where there is very limited or no
observable single-A or similar market data, interpolation and extrapolation
techniques.

Upon adoption, if interest rates increased by 100 basis points the Company's FPB
balance as of December 31, 2022, would decrease by $13.3 billion, and if
interest rates decreased by 100 basis points the Company's FPB balance as of
December 31, 2022 would increase by $10.4 billion.

See Note 7 of the Notes to the Consolidated Financial Statements for details of
future policy benefits activity.

There have been no other changes in the items the Company has identified as
critical accounting estimates during the three-month period ended March 31,
2023
. For additional information, see the Critical Accounting Estimates section
of Item 7. MD&A included in the 2022 Annual Report.

                                      106
--------------------------------------------------------------------------------

New Accounting Pronouncements


On January 1, 2023, the Company adopted LDTI employing a modified retrospective
transition method, which requires the amended guidance be applied as of the
beginning of the earliest period presented beginning on the January 1, 2021
transition date (Transition Date). The Transition Date impact from adoption
resulted in a decrease in AOCI of approximately $18.6 billion and a decrease in
retained earnings of approximately $0.3 billion.

For information on new accounting pronouncements and the impact, if any, on the
Company's financial position or results of operations, see Note 1 of the Notes
to the Consolidated Financial Statements.

Older

Q1 2023 Investor Presentation

Newer

TETRA TECHNOLOGIES, INC. ANNOUNCES FIRST QUARTER 2023 REVENUE OF $146 MILLION AND EPS OF $0.05 AND PROVIDES SECOND QUARTER GUIDANCE

Advisor News

  • Women say their advisors respect them, but talk down to them
  • How PEPs compare with traditional 401(k)s
  • Allianz studies why 42% of Americans retire sooner than expected
  • Why advisors should be talking about life settlements
  • Millennials are ready to bring their advisor to the family table
More Advisor News

Annuity News

  • NAIC regulators continue pushing for annuity illustration updates
  • Wink: Flat first-quarter annuity sales fall just short of $100B
  • 26North Re Agrees to Acquire 100% of Independent Insurance Group
  • Matthew Michelini named Athene president, with an eye on annuity growth
  • Lincoln Financial Announces Executive Leadership Transitions
More Annuity News

Health/Employee Benefits News

  • New Findings on Soft Tissue Sarcomas from National Cancer Center Research Institute Summarized (Differences Among Genomic Profiling Tests for Bone and Soft-Tissue Sarcomas in a Universal Health Insurance System): Oncology – Soft Tissue Sarcomas
  • New Clinical Oncology Findings from Basit Chaudhry and Co-Authors Described (Biosimilar adoption and provider performance in Medicare value-based payment models): Clinical Oncology
  • Arizona AG Mayes accuses health insurance companies of price fixing
  • Tom Campbell: We're paying too much for poor health care
  • Self-pay and dental care: Can paying cash without insurance help you save?
More Health/Employee Benefits News

Life Insurance News

  • Prudential announces more layoffs as insurer continues to restructure
  • Pradip Patiath Joins Securian Financial Board of Directors
  • Over $107 million in life insurance benefits located for Tennesseans in 2025
  • Study Data from National Institutes of Health Provide New Insights into Law and the Biosciences (Taking actuarial fairness seriously: what is required for the ethical use of genetics in insurance?): Legal Issues – Law and the Biosciences
  • 26North Re Agrees to Acquire 100% of Independent Insurance Group
More Life Insurance News

- Presented By -

NEWS INSIDE

  • Companies
  • Earnings
  • Economic News
  • INN Magazine
  • Insurtech News
  • Newswires Feed
  • Regulation News
  • Washington Wire
  • Videos

FEATURED OFFERS

Aim higher during Annuity Awareness Month
Raise the bar with our diverse portfolio of Ascend annuities, backed by superior financial strength

Maximize Your FIA Case Results
Learn a repeatable process to review, reposition, and present FIA opportunities with confidence.

You Could Be Losing Up to 20% of Your Commissions
GreenWave helps you find, fix, and prevent commission errors.

True Independence Means Having Choices
Cambridge offers flexibility, stability, proven tools—no private equity strings attached.

Life moves fast. Your BGA should, too.
Stay ahead with Modern Life's AI-powered tech and expert support.

Press Releases

  • RFP #T01625
  • Rockwood Programs Appoints Kerry Ladouceur as Vice President, Financial Lines
  • JP Insurance Group Launches Commercial Property & Casualty Division; Appoints Joe Webster as Managing Director
  • Sequent Planning Recognized on USA TODAY’s Best Financial Advisory Firms 2026 List
  • Highland Capital Brokerage Acquires Premier Financial, Inc.
More Press Releases > Add Your Press Release >

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Advisor News
  • Annuity Index
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • From the Field: Expert Insights
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Magazine
  • Insiders Only
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Washington Wire
  • Videos
  • ———
  • About
  • Meet our Editorial Staff
  • Advertise
  • Contact
  • Newsletters

Top Sections

  • AdvisorNews
  • Annuity News
  • Health/Employee Benefits News
  • InsuranceNewsNet Magazine
  • Life Insurance News
  • Property and Casualty News
  • Washington Wire

Our Company

  • About
  • Advertise
  • Contact
  • Meet our Editorial Staff
  • Magazine Subscription
  • Write for INN

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2026 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • InsuranceNewsNet Magazine

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.
Insurance News | InsuranceNewsNet